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FOREWORD
Since the first report in this series1 became available, the
modernisation of the National Health Service across the
United Kingdom and community pharmacy’s role within
that has steadily progressed. The plans set out by the UK
Government2 and devolved administrations3 outlined a
vision for developing the NHS and pharmacy services that
gave the needs of those who use the service much higher
priority and, especially, focused on improving access to
care.
Many initiatives that were outlined in those plans – for
example proposals for supplementary prescribing and
Local Pharmaceutical Service pilots – have now begun to
be put into practice and their potential for improving
services to patients will soon become apparent. Both
general medical practice and pharmacy have been
equally affected by these developments, which have
often served to bring the two professions closer together
to deliver better patient care.  
One area for development that still remains relatively
unexplored is the potential contribution that community
pharmacy can make to improving the public’s health and
how it can work more closely with general medical
practice to achieve this. In some instances – for example
in smoking cessation4 – there is a relatively good history
of co-operation between general practice, the NHS
smoking cessation services and community pharmacy
across the UK which has served to ensure that patients
vii
1  Anderson C, Blenkinsopp A and Armstrong M (2003). The 
contribution of community pharmacy to improving the public's health. Report 1: Evidence from
the peer-reviewed literature 1990 – 2001. Launched at the British Pharmaceutical Conference in
September 2001 and is available on the website: www.rpsgb.org.uk/patientcare/. 
2  For example, see the Department of Health policy documents: The NHS Plan: a plan for investment.
A plan for reform (2000) and Pharmacy in the future: implementing the NHS Plan (2000).
3  For example, see the Scottish Executive documents: Our National Health: A plan for action, a 
plan for change (2000) and The right medicine: a strategy for pharmaceutical care in Scotland
(2002); and the National Assembly for Wales document: Improving health in Wales – a plan for
the NHS and its partners (2001) and the Welsh Assembly Government consultation document:
Remedies for success: a strategy for pharmacy in Wales (2002).
4  A survey of all UK NHS commissioning bodies was undertaken in 2002 to assess the existing 
number of health improvement projects that involved community pharmacies. The findings
indicated that the most common health topic by far for community pharmacists to be involved
with was smoking cessation and that these projects were evenly spread throughout the UK. See
the report Local pharmacy health development projects – testing models of implementation in
community pharmacy (2002) – unpublished work available on request from
pharmacyhealthlink@rpsgb.org.uk or 020 7572 2265 – for more details.
have access to a comprehensive ‘stop smoking’ service at
a local level. In other areas of prevention however – for
example sexual health and drug misuse services – there is
much less evidence that these services are either in
existence or that there are plans for their development.
The main purpose of the second report is to outline
additional evidence from the non peer-reviewed
literature indicating which health improvement topics
might be appropriately tackled within a community
pharmacy setting and how these are best delivered.
Relevant findings from the first report have also been
included to help this assessment. 
In addition this report provides much more detail on the
relationship between, and attitudes of, the different
stakeholders concerned with improving the public’s
health in a community pharmacy setting. Pharmacy users’
views, in particular, provide a very interesting perspective
on service provision that we hope will encourage health
service planners and general medical practitioners to
think more broadly about how the ‘added value’ of easy
access to community pharmacies might help deliver their
public health objectives.
Professor Professor
Sian Griffiths David Haslam
President Chairman of Council
Faculty of Public Royal College of General
Health Medicine Practitioners
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EXECUTIVE SUMMARY
Aim
To identify and critically appraise the non peer-reviewed
UK research on the contribution of community
pharmacists to improving the public's health.
Background
Community pharmacies and pharmacists have the
potential to contribute to the public’s health and there is
a history of over two decades of developmental work in
this setting in the UK. The position of community
pharmacies straddles both public and private sectors, the
former primarily through a nationally-negotiated NHS
contract to dispense prescriptions. Pharmacies’ dual
health and commercial roles offer a unique opportunity
to target activities towards healthy people as well as
those with existing health problems. For this to occur in
the most effective way, service commissioners need access
to the evidence of potential benefit – hence the current
literature review.
Method
Sources of non peer-reviewed literature were identified
through key informants, and a survey of academic
departments of pharmacy and related subjects. Criteria
were developed for a review of research quality and a list
of inclusion criteria for the review was constructed.
Results
In total, 45 studies were identified, 37 of which were
included in the review. The most common reason for
exclusion was a low survey response rate. Community
pharmacists (27 studies), pharmacy users (22 studies) and
primary health care team members (7 studies) were the
most frequently included participant groups. Twelve
studies involved the investigation of both pharmacist and
stakeholder attitudes towards pharmacists’ role in health
improvement. Thirteen studies addressed general health
issues and 24 covered specific health topics, of which the
1
most commonly studied were sexual health, including
emergency hormonal contraception (9 studies) and head
lice management (4 studies).
Many of the findings from this review confirmed, or
added further information to, the findings from the
peer-reviewed literature (Report 1 of this series). To help
identify the key discussion points the main findings of
this report have been presented as answers to various
questions.
Where does the non peer-reviewed literature 
provide confirmatory evidence of the findings of the
peer-reviewed literature?
The non peer-reviewed literature supported the findings
from the peer-reviewed literature in the following areas:
• Both community pharmacists and pharmacy users 
perceive pharmacists’ roles in improving the public’s
health to be primarily medicines-related. 
• Public use of community pharmacies is almost 
universal but is low for general health advice.
• The actual experience of service users is generally 
more positive than their prior perceptions of access
to, and value of, advice and services from community
pharmacies. 
• Pharmacists have concerns about the receptiveness of 
GPs and the public to any extended role for them in
health improvement and, as a result, their willingness
to opportunistically offer general health advice is
reduced. 
• Pharmacy patient medication records were found to 
be effective in identifying ‘at risk’ patients to prompt
and enable pharmacist intervention for influenza
vaccination.
• Training has a positive effect on pharmacists’ 
consultation and information-giving behaviour.
2
3Where does the non peer-reviewed literature provide
new evidence?
New or additional evidence was found in the following
areas:
Health topics
• Drug misuse services – the studies reviewed found 
that most drug misusers value community pharmacy-
based services highly. Positive pharmacist attitudes
were correlated with higher levels of service provision
for drug misusers but practising pharmacists had
more negative opinions than undergraduate
pharmacy students.
• Sexual health – public interest in the availability of 
advice on contraception and safer sex through
pharmacies is high. Whilst pharmacists express
considerable support for their involvement in
promoting safer sex and contraception, they report
that they are rarely asked for such advice, and they
are reluctant to offer it proactively.
• Emergency hormonal contraception (EHC) – the 
review extended the available evidence on EHC
supply through community pharmacies, particularly
through feedback from some 1600 users in three
major studies. Pharmacy supply of EHC enables most
women to receive it within 24 hours of unprotected
sexual intercourse and services were highly rated by
women. Feedback from pharmacist providers was
mainly positive and there was a clear wish to extend
the use of Patient Group Directions to enable supply
to under-16-year-olds. 
• Head lice management – evidence based on 
evaluations of over 8600 head lice consultations in
two community pharmacies was reviewed. Quality
indicators included the percentage of consultations
where no treatment was provided, requirements for
proof of infestation, adherence to local treatment
formularies and feedback from users, pharmacist
providers and other health professionals. Overall
one-quarter to one-third of consultations resulted in
no treatment being supplied. Adherence to treatment
formularies by community pharmacists was close to
100%. Feedback from scheme users, pharmacist
providers and other health care professionals was
predominantly positive.
Factors affecting community pharmacy-based
activities to improve health
The review extended the evidence on pharmacy users’
views on privacy and confidentiality in the pharmacy.
Most pharmacy users of potentially sensitive services – for
example EHC and head lice management – reported
adequate facilities for privacy in community pharmacy
but a sizeable (up to 20%) minority consistently
expressed some concerns. The perceived concerns of
pharmacy users about privacy, however, are generally not
borne out in the reports of actual experience, although
community pharmacists and users appear to have
different perceptions of what constitutes acceptable
facilities for maintaining privacy. Up to 20% of women
obtaining EHC from community pharmacies reported
having concerns about confidentiality and this was
higher among those under 19 years of age.
The review showed that while community pharmacists
consider leaflets to be an important component of their
toolkit for improving the public’s health, passive displays
of leaflets may be missed by half of pharmacy customers.
Multimedia technology appears to be a means of
engaging young and healthy pharmacy customers in
health improvement activities.
Stakeholder views
The non peer-reviewed evidence shows that the new
community pharmacy service developments in EHC supply
and head lice management were well received by other
primary care health professionals. The extent of sustained
joint working between community pharmacists and other
members of the primary health care team was low
(although it is noteworthy that these studies were from
4
5the mid-1990s). There was some evidence that joint
working might be improved by joint training.
Where does the non peer-reviewed literature indicate
potential for further development?
The following areas were identified as being worthy of
further research and investigation of feasibility:
• Use of aspirin in the prevention of coronary heart 
disease – pharmacists are perceived by people taking
prophylactic aspirin as an appropriate potential
source of advice on aspirin and heart disease. These
patients have unmet information needs that they
perceive could be met by pharmacists but generally
this is not done at present.
• Oral health – the evidence indicates that a more 
proactive approach by community pharmacists is
needed to maximise opportunities for improving oral
health. Most requests for paediatric over-the-counter
medicines in pharmacies were for named medicines,
indicating that active intervention from the
pharmacist would be needed to change purchasing
patterns towards sugar-free alternatives. Training and
participation in oral health promotion activities
appeared to increase pharmacists’ efforts to try to
change people’s medicine-buying behaviour.
• Mental health – little evidence was found on 
community pharmacist involvement in improving
mental health. A study of pharmacy users, however,
showed that they purchase products to reduce stress
and anxiety and take up leaflets available in
pharmacies on these topics – particularly on sleep
problems and relaxation – indicating that there may
be a role for pharmacists to proactively offer more
support. The vast majority of pharmacy users, though,
did not name the pharmacist as their preferred source
of advice on stress and anxiety.
• Prevention of transmission of infection – community 
pharmacists were found to have generally positive
attitudes towards involvement in prevention of
transmission of infection but to have variable
knowledge about the transmission of HIV, hepatitis B
and hepatitis C. In conjunction with the findings from
immunisation and drug misuse services, there appears
to be potential for further exploring the health
protection role of community pharmacists.
• Accidental injuries: falls prevention – a pharmacy-
based osteoporosis screening service involving
pharmacist and nurse input in one pharmacy was
found to be feasible and identified women at risk of
osteoporosis.  Women using the scheme valued the
accessibility offered by community pharmacy.
• Accidental injuries: medicines-related injuries – a 
study of unwanted medicines returned to community
pharmacies during a local campaign showed that
changes in therapy and adverse effects from
treatment were key reasons why excess quantities of
medicines occurred in people’s homes. Subsequent
discussions between the pharmacists and local GPs
appeared to be useful for making changes in
prescribing frequency to reduce wastage.
Discussion  
The search of non peer-reviewed literature identified
some high quality research studies that usefully
contributed to the evidence base. In particular, studies
provided a wealth of further evidence of users’ and
stakeholders’ feedback on pharmacy services, identification
of the key elements of effective pharmacy-based health
improvement activities and on the effectiveness of
various approaches to different health topics. 
The non peer-reviewed studies were graded using the
same framework for research quality as that used for
peer-reviewed studies and hence were considered against
the same standards.  
The non peer-reviewed literature confirms some of the
key findings from the peer-reviewed literature (Report 1).
Firstly, community pharmacists are generally viewed by
the public as experts who advise on medicines rather
than on health and illness. Secondly, members of the
6
7public report they are willing to receive further
information on health issues from community
pharmacists but are not currently receiving this advice.
Thirdly, community pharmacists can provide effective
health improvement activities for: smoking cessation;
coronary heart disease prevention; immunisation (and
identification of high risk cases for intervention by using
patient medication records); supply of EHC; head lice
management; and drug misuse services. Lastly, training
has the potential to significantly change community
pharmacists’ behaviour and positively orientate their
practice towards health improvement. 
In addition the ‘grey’ literature provided further details
about the perceived problems and acceptability of
community pharmacists providing advice and services on
sensitive health issues, such as the supply of EHC and
head lice management. Specifically there were important
findings on pharmacy user perspectives of privacy and
confidentiality. Most users of these services reported
satisfaction with the level of privacy available, but
20–25% felt there was insufficient privacy. These findings
suggest that pharmacists need to consider whether their
premises provide sufficient privacy to meet the needs of
all users.  Data on perceptions of confidentiality of
pharmacy information came from EHC service users and
indicate that about 20% had concerns about
confidentiality. These findings suggest that the pharmacy
profession should consider additional ways of informing
the public about the requirement for pharmacists to
maintain confidentiality.
The non peer-reviewed literature also demonstrates the
potential of community pharmacies to contribute to
reductions in health inequalities.  People living in
deprived areas and who are less affluent are among the
most frequent users of pharmacies.  
Conclusion
The non peer-reviewed literature strengthens the overall
picture of evidence by: confirming the key findings of
Report 1; adding new material on specific health topics
and on the relationships between community pharmacists
and the primary health care team; and providing further
insights into pharmacist and user attitudes and
behaviours.
Users express a high degree of interest in the availability
of further information and advice from pharmacists,
although the pharmacist is not seen as a primary source.
The research findings suggest considerable scope for joint
working of pharmacists, pharmacy users and healthcare
commissioners to develop pharmacies as a local and
accessible advice point complementary to existing
services.
Further research is needed to investigate the potential
role of the community pharmacist in sexual health, oral
health, mental health, the prevention of transmission of
infection and accidental injuries. Research is also needed
to track the development of collaborative working
between community pharmacists and other members of
the primary health care team within the new NHS
infrastructure, and to measure any change in the public’s
perception of the pharmacist’s role in providing health
improvement activities. Evaluation of innovative
approaches to services and premises development will
also be crucial to informing service design to meet the
needs of users, particularly in relation to queries about
approaching the pharmacist for general health advice
and perceptions about privacy and confidentiality.
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91  INTRODUCTION
During the last decade there has been considerable
interest and activity in research into the public health
role of community pharmacies. Despite an increasing
number of initiatives (including a recent European
Commission project)1 there were no recent reviews of the
strength of evidence for the wider implementation of
public health programmes in community pharmacies. In
addition there was a broader need to clarify definitions
used to describe public health activities in pharmacies, to
identify which activities were most suited to a community
pharmacy setting and to determine which activities
warranted further research investment.
To help address these issues the charity
PharmacyHealthLink and the Royal Pharmaceutical
Society of Great Britain commissioned a critical review of
the UK and international literature relating to the
community pharmacy’s contribution to improving the
public’s health as part of a wider work programme to
determine what activities are most likely to be effective
in a community pharmacy setting and how they might
best be provided.
Report 1 reviews the findings of the peer-reviewed
literature, which includes peer-reviewed journals and
conference proceedings. Report 2 reviews the non peer-
reviewed literature and examines aspects of
implementation in more detail. The final report (Report
3) summarises all the material reviewed and makes
recommendations for action.
Aim of the review
The aim was to identify and critically review the non
peer-reviewed UK research on community pharmacists’
contribution to improving the public’s health. Non peer-
reviewed (‘grey’) literature was defined as research that
was produced as a formal report or thesis but where the
findings were not available in peer-reviewed journals.
1  See www.univie.ac.at/phc for more details on this initiative.
Scope of the review
Definitions
The review included activities described by the following
widely used definitions of health promotion and public
health:
• Health promotion
The Ottowa Charter for Health Promotion (WHO, 1986)2
states that ‘Health promotion is the process of enabling
people to increase control over, and to improve, their health’.
• Public health
Public health has been defined as ‘the science and art of
preventing disease, prolonging life and promoting health
through the organised efforts of society’ (Acheson
inquiry into the future development of the public health
function, 1988).3
Activities included / excluded
Specifically, the review included pharmacy activities for
both individuals and wider communities relating to:
• Promoting health and well-being (e.g. nutrition, 
physical activity).
• Preventing illness (e.g. smoking cessation, 
immunisation, travel health).
• Identifying ill health (e.g. screening and case finding).
• The maintenance of health for those with chronic or 
potentially long-term conditions (e.g. diabetes,
asthma, hypertension).
The advice-giving role of the pharmacist in relation to
the treatment of acute self-limiting conditions, the
management of minor illness, prescribing and
prescription reviews was not included because it has been
covered elsewhere.4
10
2  WHO (1986).  Ottowa Charter for Health Promotion. First international conference on Health 
Promotion, Ottowa, 21 November 1986. Geneva: World Health Organisation.
3  Public health in England: the report of the Committee of Inquiry into the future development of 
the public health function, Cm 289, 1988. London: The Stationery Office.
4  See, for example, The Public’s Use of Community Pharmacies as a Primary Health Care Resource 
(1998) – research carried out by the University of Manchester School of Pharmacy and the National
Primary Care Research and Development Centre for the Community Pharmacy Research Consortium.
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The literature review focused on activities taking place
within the community pharmacy setting or activities
carried out by community pharmacists and their staff in
other settings, for example, nursing homes. The work of
pharmacists in primary care and strategic roles was
included where relevant.
Criteria for inclusion of evidence
The majority of dissemination of research is based on a
hierarchy of evidence with the randomised controlled
trial (RCT) as the ‘gold standard’. The literature in the
field of pharmacy practice/public health contains few
RCTs, and a substantial number of experimental studies
and descriptive work. This review used two approaches to
assess the quality of evidence: (1) the Health
Development Agency’s Evidence Base 20005 standards for
transparency, systematicity and relevance; and (2) the
categorisation of evidence according to the system used
by the Department of Health in its National Service
Frameworks.6
Health Development Agency standards: 
Evidence Base 2000
• Transparency – evidence must include a clear and 
transparent account of how it was collated, which
sources of information have been consulted, who was
involved in collating the evidence, how the work was
funded, a full disclosure of any analysis and findings.
• Systematicity – evidence identified must display 
clearly, regardless of the individual study, report or
review methodology, the process through which the
evidence was gathered and assessed.
• Relevance – evidence must be judged to be relevant 
to health improvement, and in this instance to the
role of community pharmacy.
5 See, for example, Health Development Agency's website 
(www.HDA-online.org.uk/evidence/eb2000): Evidence base – quality standards for evidence.
6 See, for example, page 11 of the National Service Framework (NSF) on Services for Older People,
Department of Health, March 2001.
National Service Frameworks: categorisation of
evidence
The Department of Health categorises individual studies
according to the standard classification set out in its
National Service Frameworks:
Evidence from research and other professional literature
A1 Systematic reviews that include at least one 
randomised controlled trial (RCT) e.g. systematic
reviews from Cochrane or NHS Centre for Reviews
and Dissemination.
A2 Other systematic and high quality reviews which 
synthesise references.
B1 Individual RCTs.
B2 Individual non-randomised, 
experimental/intervention studies.
B3 Individual well-designed non-experimental studies, 
controlled statistically if appropriate. Includes studies
using case control, longitudinal, cohort, matched
pairs or cross-sectional random sample
methodologies, and well-designed qualitative
studies, well-designed analytical studies including
secondary analysis.
C1 Descriptive and other research or evaluation not in B 
(e.g. convenience samples).
C2 Case studies and examples of good practice. 
D Summary review articles and discussions of relevant 
literature and conference proceedings not otherwise
classified. 
12
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2. METHOD
Identifying non peer-reviewed research
Two sources were used:
• Key informants in England, Scotland, Wales and 
Northern Ireland.
• Schools of Pharmacy and postgraduate pharmacy and 
medicines management departments (n = 20) in
England, Scotland, Wales and Northern Ireland.
Key informants were contacted and asked to identify any
reports of research involving pharmacists improving
health that had not subsequently been the subject of
publication in peer-reviewed journals. Copies of the
reports identified were obtained. The period for
collecting evidence was January 1990 to October 2002.
A named individual in each School of Pharmacy was
contacted by e-mail in February 2002, with a reminder in
March 2002. Respondents were informed of the context
of the review (the role of the pharmacist in public health
and health promotion) and asked to identify relevant
MSc, MPhil and PhD research submitted between 1990
and 2002. They were asked to send a copy of the title
page and abstract from each relevant thesis. Where the
abstract contained insufficient information the individual
research student was contacted to obtain it.
Review of research quality
Each item was read by one of the authors (AB) and the
following inclusion criteria were applied:
(i)   Reported original research.
(ii)  Sufficient methodological detail on study 
design, sampling and response rate.
(iii)  Adequate methodological design.
(iv) For surveys, response rate: over 50%.
(v)   Topic within improving health remit.
(vi)  Reported within review timeframe.
Data abstraction and construction of
the review
Data (see Appendix 2) were extracted from each item
and summarised under the following headings:
• Identifiers: title, author/s, source type (report, thesis), 
year of publication, evidence grade (using
Department of Health National Service Frameworks
categories – see Appendix 1)
• Objectives
• Study design
• Sample and response rate
• Key findings
• Other comments
A draft containing six items (four proposed for inclusion,
two for exclusion) was then read by a second author (CA)
and the project Steering Group. There was agreement
about application of the inclusion/exclusion criteria.
14
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3. RESULTS
Studies included and excluded
Of the 45 studies identified, 37 were subsequently included
in this review. Research abstracts on subjects within the
remit of the review were received from eight university
departments. One report was identified that was published
immediately before the timeframe of the review (1989)
and the decision was taken by the Steering Group to
include it on the grounds that it was a major study, the
findings of which were not otherwise disseminated.
Table 1. Studies considered for the review
Type Number Included Reasons for exclusion
identified
Commissioned 24 22 Not research
work Low response rate
MSc/MPhil/PhD 13 11 Low response rate
Outside remit
Other 8 4 Low response rate (2)
Not research (1)
Outside remit (1)
The results presented in the next section relate to the 37
studies included in the review. The most common reason for
exclusion from the review was a low survey response rate.
The identified studies involved pharmacists, other
primary health care team members and pharmacy users.
Table 2 summarises the study participants. Most studies
included pharmacists or users as the respondent group.
Table 2. Study participants
Pharmacists (community) 27
Pharmacy users 22
Primary health care team members 7
Pharmacy assistants 3
Pharmacists (other) 3
Other 2
Ten of the studies involved community pharmacists alone
and eight involved users alone. Twelve studies involved
investigating both pharmacist and stakeholder attitudes
towards pharmacists’ role in improving the public’s
health. Four studies included data collection on
medicines purchased from or returned to pharmacies. Six
projects included small scale feasibility trials and one PhD
thesis described the development and implementation of
an RCT on community pharmacists’ advice on smoking
cessation. The latter was one of five sources where peer-
reviewed publications had eventually resulted.
Thirteen studies addressed general issues in health
improvement from the perspectives of pharmacists,
pharmacy users and stakeholders and four focused on a
specific health topic (Table 3). 
Table 3. Specific health topics and the number of
studies involved
Sexual health (including emergency hormonal contraception) 9
Head lice management 4
Drug misuse 3
Accidental injury prevention 2
Smoking cessation 1
Oral health 1
Coronary heart disease – the use of aspirin in prevention 1
Mental health 1
Immunisation 1
Prevention of transmission of infection 1
Presentation of findings
The findings are presented in three main categories:
• Health topics.
• Factors affecting the effectiveness of community 
pharmacy-based activities to improve health. 
• Stakeholder views.
16
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The findings in the Results section have been presented
in a similar format to Report 1 on the peer-reviewed
literature with the key statements of evidence being
highlighted in the text. This is followed by a brief
summary of the studies. Further points for analysis or
discussion appear in side bars to the text. The key
evidence statements are presented in descending order
of strength of evidence (as classified by the Department
of Health National Service Frameworks grading of
evidence – see Appendix 1).
Some key evidence statements arising from the peer-
reviewed literature have been replicated here where
relevant to the findings of the non peer-reviewed
literature. 
Please note that the findings presented here summarise
the evidence reviewed for these two Reports only and
therefore each evidence statement needs to be
considered within the broader framework of factors
affecting community pharmacy-based services. These
factors have been given some consideration in the form
of analysis / discussion points for each topic presented in
the Results section of Reports 1 and 2, but a more
general overview of these factors and their influence is
presented in the Discussion sections of each report. The
analysis/discussion points in this document refer to the
non peer-reviewed literature only.
Health topics
Smoking cessation 
Relevant finding from peer-reviewed literature:
• Community pharmacists trained in behaviour change 
methods are effective in helping clients stop smoking
(B1).
Key finding from non peer-reviewed literature:
• Training increases knowledge, self-confidence and 
positive attitude of pharmacists and their staff in
relation to smoking cessation (B1).
The systematic involvement of other pharmacy staff in
service provision was a feature of Sinclair’s trial of the
effect of training (B1: Sinclair 1997, p65). Pharmacy staff
and pharmacists were invited to attend joint training
events with the intention of developing a practice team
approach to the service. Training significantly increased
knowledge, self-confidence and positive attitudes about
the outcome of counselling in intervention teams
compared with controls.
Coronary heart disease – the use of aspirin
in prevention
Relevant findings from peer-reviewed literature:
• Community pharmacy audits can identify self-initiated 
aspirin treatment and encourage referral for medical
advice (B3).
• Community pharmacy-based monitoring of the use of 
prophylactic aspirin treatment shows promise but
more evidence is needed (B3).
Key findings from non peer-reviewed literature:
• The pharmacist is perceived by pharmacy users to be 
an appropriate potential source of advice on aspirin
and heart disease (C1).
• Pharmacists are not perceived by patients taking 
aspirin to be currently providing the advice they need
(C1).
• Patients taking aspirin prophylactically have unmet 
information needs that could be provided for by
community pharmacists (C1).
The pharmacist was found to be considered a highly
appropriate source of advice on both aspirin and
coronary heart disease (CHD) prevention in a telephone
interview study with 108 people receiving aspirin (C1:
Kinghorn 1998, p65). However, pharmacists were not
considered to be providing this service currently, and
perceived lack of privacy in pharmacy premises was an
issue. The research identified information needs in
relation both to aspirin itself and CHD and its prevention.
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Analysis / discussion point:
The research findings show
potential benefit from a whole
staff approach in community
pharmacy, although there are no
comparative data when
pharmacists alone have provided
the service. Further research into
the effects of community
pharmacy team approaches on
service provision capacity, quit
rates and number of people
setting a ‘quit date’ is needed.
Analysis / discussion point:
The research findings suggest that
patients taking aspirin
prophylactically need more
information and advice than they
receive at present and would find
the community pharmacist an
acceptable source for this.
Pharmacy users, however, report
not receiving this advice possibly
because patients are reluctant to
ask for further information, but
also perhaps because a lack of
privacy was cited as an issue by
some. Given the clear evidence of
benefit from prophylactic aspirin
use in the prevention of CHD and
that monitoring of the use of
aspirin purchased over the counter
from community pharmacies is
feasible, primary care
organisations should be aware of
how community pharmacy-based
services might be integrated into
local service provision as a means
of reducing rates of heart disease.
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The findings indicate patient information needs that
could be met through pharmacies.
Drug misuse
Relevant findings from peer-reviewed literature:
• Community pharmacy-based supervised methadone 
administration services can achieve high attendance
rates and can be acceptable to clients (B3).
• Specific training needs have been identified for 
pharmacists participating in pharmacy-based needle-
exchange schemes (C1).
Key findings from non peer-reviewed literature:
• Most drug misusers value community pharmacy-based 
services highly (B3).
• Practising pharmacists appear to have more negative 
opinions about drug misusers than undergraduate
pharmacy students (B3).
• Positive pharmacist attitudes are correlated with 
higher service provision for drug misusers (B3).
• Training for pharmacists needs to include skills in 
translating technical terms into a suitable language
for drug misusers (C1).
Three studies were identified, the first investigated the
attitudes of pharmacy undergraduates, pharmacists and
clients towards the pharmacist’s role in HIV and drug
misuse (B3: Sheridan 1995, p66), the second described
client queries addressed to a pharmacist in a primary care
drugs agency service (C1: Scott 2000, p67) and the third a
study of community pharmacists and drug users’
perspectives on service provision (B3: Matheson 1999,
p66). Pharmacy undergraduates and practising
pharmacists were found to have positive professional
opinions and some negative personal opinions about HIV
and drug misuse. The practising pharmacists tended to
have more negative personal opinions, suggesting an
effect from practice experience. Drug information queries
from drugs agency workers formed the most frequent
Analysis / discussion point:
The research has identified a
range of issues from service user
and provider perspectives that
have implications for professional
education and training of
pharmacists and for the planning
and organisation of services.
Understanding the reasons for
negative attitudes from
pharmacists not involved in
service provision will require the
collection of evidence-based data
to support or refute pharmacist
perceptions. Continued feedback
from service users can supply an
important part of this.
category of requests to the pharmacist, with numbers
slightly higher for prescribed than non-prescribed drugs
(C1: Scott 2000, p67). The key specialist skill required was
reported to be translating technical information into
terms used as part of the ‘drug culture’. 
In a national study of attitudes of Scottish community
pharmacists and their practice in relation to services for
drug misusers, a postal questionnaire and interviews
were used. The questionnaire mapped provision of
services by community pharmacies and explored
pharmacists’ attitudes. More positive attitudes were
correlated with higher levels of service provision.
Pharmacists had concerns about the effects on other
customers of service provision for drug misusers. Drug
misusers valued services provided by community
pharmacies. The study showed the importance of the
relationship between pharmacists, their staff and service
users. Some drug misusers reported negative experiences
that had increased their feelings of stigma (B3: Matheson
1999, p66). 
Sexual health
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature:
• Public interest in the availability of advice on 
contraception and safe sex through pharmacies is
high (B3).
• Quality and confidentiality were identified by 
pharmacy users as important considerations in
selecting a pharmacy for advice on women’s health
(B3).
• Pharmacists express support for involvement in 
promoting safer sex and contraception but are rarely
asked for such advice and are reluctant to offer it (B3).
• Male pharmacists perceive themselves as less 
knowledgeable and more embarrassed than female
pharmacists in discussing women’s health issues (B3). 
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Analysis / discussion point:
The ‘grey’ literature confirms there
is a desire by the public for easy
access to information on both
contraception and safer sex (an
important finding in its own right
set against a backdrop of
increasing rates of infection in
certain sexually transmitted
infections and HIV/AIDS) and that
they would be prepared to receive
this advice from pharmacists. In
comparison, the extent to which
pharmacists can offer advice
appears to be limited by their
training (in particular, how
comfortable they feel talking
about sexual health issues) and
their willingness to respond to
enquiries. Health service
commissioners need to consider 
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Two studies explored the community pharmacist’s role in
sexual health issues including safer sex and contraception
(B3: Campbell Keegan 1992, p67; B3: Hughes 2000, p68).
Although 86% of pharmacists thought that pharmacists
had an important role in promoting safer sex and
contraception, almost three-quarters reported being
asked for advice on contraception less than once a week.
The researchers noted that pharmacists generally took a
reactive role, providing advice when asked (B3: Campbell
Keegan 1992, p67). Public interest in the availability of
advice from pharmacists was high, with 64% agreeing
that they would like more advice from the pharmacist on
contraception and safer sex (B3: Campbell Keegan 1992,
p67). In Hughes’ (2002) study, involvement in sexual
health promotion was found to be limited and to occur
entirely as a result of customer queries. Many of the
community pharmacists who took part felt
uncomfortable with this area of advice. 
Community pharmacists’ knowledge of and attitudes
towards women’s health were investigated in a study of
pharmacists and users (B3: McAree 2001, p69).
Pharmacists, completing a postal questionnaire, reported
that they were not embarrassed to discuss many sexual
health issues although some concerns were expressed
about confidence and knowledge deficits. Male
pharmacists perceived themselves as less knowledgeable
and more embarrassed than did females. Users identified
factors that might influence their decision about whether
to use a community pharmacy including quality and
confidentiality.
Emergency hormonal contraception
Relevant findings from peer-reviewed literature:
• Emergency contraception can be effectively and 
appropriately supplied by pharmacists (B3).
• Pharmacists were positive about their experience of 
providing emergency hormonal contraception (EHC)
(B3).
• Users were satisfied with the service pharmacists 
provided (C1).
how pharmacies might play a
greater part in national and local
sexual health strategies and also
in reducing teenage pregnancy
rates. Pharmacists’ access to up-
to-date postgraduate training that
incorporates and encourages
networking with other local
service providers is likely to be
crucial in increasing pharmacists’
confidence in dealing with these
issues appropriately and
effectively.
Key findings from non peer-reviewed literature:
• Pharmacy supply of EHC enables most women to 
receive EHC within 24 hours of unprotected
intercourse (B3).
• Community pharmacies are highly rated by women as 
a source of supply and associated advice for EHC on
prescription, by Patient Group Directions or over the
counter sale (B3).
• A small minority (10%) of women choose pharmacy 
supply of EHC in order to maintain anonymity (B3).
• Pharmacists report predominantly positive 
experiences of involvement in supply of EHC through
Patient Group Direction and over the counter (B3).
• Pharmacists wish their services for supply of EHC to 
develop in order to meet women’s needs at a local
level, particularly through increased use of Patient
Group Directions to supply under-16-year olds (B3).
• The role of other pharmacy staff in provision of EHC 
services is reported by pharmacists to be important
but there are no data to enable assessment of their
contribution (B3).
Six studies on emergency hormonal contraception (EHC)
were identified, three explored consumer perspectives
and experiences, two focused on community pharmacists
and one included both. Three surveys investigated the
experiences of consumer and community pharmacists one
year after EHC became available over the counter (B3:
Lambeth, Southwark and Lewisham Health Action Zone
2002, p69; C1: Pharmacy Alliance 2002a, p70; B3: Pharmacy
Alliance 2002b, p71). 
Pre-deregulation
Two focus group studies on EHC, one with 14 community
pharmacists (B3: Seston, 2000, p72), the other with 10
groups of users (B3: Edwards, 2000, p72) were reviewed.
Both were conducted prior to the deregulation of EHC
from prescription only to pharmacy medicine status.
Pharmacists accorded EHC a special status in comparison
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to other POM to P (prescription only medicine to
pharmacy medicine) switches and supported mandatory
training. Users were positive about the POM to P switch
increasing accessibility and convenience. The consumer
study identified the questions that women had about
safety and effectiveness of EHC together with ‘myths’
about how often EHC could be taken and its effect on
future fertility. Another study explored the attitudes of
community pharmacists to pharmacy supply of EHC as
part of wider research on the role of pharmacists in
contraception and sexual health advice (B3: Hughes 2000,
p68). Community pharmacists saw more scope for
involvement in EHC supply than in other aspects of
contraception. Pharmacists’ reasons for support for EHC
supply included a perceived increase in their status as
well as a business opportunity.
A study of consumer and pharmacist perspectives on
supply of EHC in the first Patient Group Direction scheme
in Manchester included a questionnaire and focus groups
with scheme users, interviews with pharmacists and
‘mystery shopper’ visits to pharmacies (C1: Anderson et al
2001, p70). The scheme was highly-rated by users, who
valued the enhanced access to treatment. Most (85%)
were content with the level of privacy available. Similarly
most were satisfied with perceived confidentiality of the
consultation, although those under 19 years of age
expressed more concerns about this aspect. Some scheme
users had found difficulty in identifying which
pharmacies provided the service and when they were
open, indicating a need for more effective publicity.
Pharmacists were generally positive about their
involvement, viewing the scheme as valuable both to its
users and to the profession of pharmacy. Some
pharmacists expressed concerns about the increased
workload generated by the scheme and about different
remuneration policies of pharmacist employers. 
Post-deregulation
User views
Women purchasing EHC, receiving it on prescription or
through a Patient Group Direction were asked to
complete a questionnaire by the pharmacist one year
after EHC was deregulated to a pharmacy medicine (C1:
Pharmacy Alliance 2002a, p70). From 250 pharmacies that
participated in the survey, 785 women (30%) returned
completed questionnaires. The results showed that just
over half of the EHC was supplied as an NHS medicine,
either as a prescription (42.4%) or under a Patient Group
Direction (13.6%), compared to 44% purchasing EHC over
the counter. Almost three-quarters (71%) of the women
accessed EHC within 24 hours after unprotected
intercourse, an important consideration as the efficacy of
EHC is time-dependent, being most effective if taken
within 24 hours after intercourse. There was a high level
of satisfaction with the amount of advice and
information received from the pharmacist. Pharmacies
were highly rated as a suitable place to obtain and
discuss EHC. Approximately one in ten women cited
anonymity as a key reason for pharmacy purchase of EHC.
Women who had accessed EHC through a community
pharmacy Patient Group Direction scheme in one area of
London were surveyed as part of the evaluation of the
programme (B3: Lambeth, Southwark and Lewisham
Health Action Zone 2002, p69). In total 315 (20%) women
returned the survey questionnaire, which was distributed
through pharmacies participating in the scheme. Overall
98% of user respondents were ‘Satisfied’ or ‘Very
satisfied’ with the service. The majority (90%) had felt
‘Comfortable’ or ‘Very comfortable’ discussing their
request with the pharmacist. Overall one-quarter of
respondents had concerns about confidentiality with the
proportion being higher in women under 20 years of age. 
Pharmacist views
In a national survey of community pharmacists’
experience of selling and supplying EHC 1426 (64%)
responded, of which 94% worked regularly in the
pharmacy from which the survey was completed (B3:
Pharmacy Alliance 2002b, p71). Almost all pharmacists
(98.9%) said they would supply EHC on prescription and
89.4% said they would sell it over the counter. Overall
20% of respondents were already participating in a
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scheme to provide EHC through a Patient Group
Direction and a further 51% said they would be willing
to do so. These figures show a high level of commitment
from pharmacists to the supply of EHC and demonstrate
scope for extending Patient Group Direction supply.  
The survey report was able to compare pharmacists’
responses with those from a previous questionnaire in
1997. In the current survey pharmacists disagreed that
over the counter availability had resulted in increased
promiscuity or sexual activity, a concern that significant
numbers had expressed in 1997. In addition, pharmacists
did not agree that they had found it difficult to deal
with teenagers’ requests for EHC, allaying another
concern expressed in 1997. These findings demonstrate
that practical experience of supplying EHC over the
counter showed previous concerns to be unfounded.
Instead pharmacists felt that over the counter availability
of EHC had provided an opportunity to develop new
counselling skills and 91% reported undertaking training
to prepare for their new role with EHC. 
The survey also asked about pharmacists’ views on
supplying EHC to those under 16 years of age. While
respondents were not in favour of supplying EHC to
under-16s as an over the counter medicine, they did not
agree that all under-16s requesting EHC from the
pharmacy should be referred elsewhere. These findings
suggest that pharmacists wish to use their professional
judgement when supplying EHC and this is further
confirmed by their support for the supply of EHC via
Patient Group Direction to females aged under 16 years.
However, of the 284 pharmacists involved in Patient
Group Direction schemes, 66% (136) reported that under-
16s were excluded from their local scheme. In addition,
respondents agreed that the price of over the counter
EHC was a deterrent to women purchasing it. Overall the
findings suggest that pharmacists believe that improved
access to EHC is needed for some women through NHS
supply under Patient Group Direction. The survey showed
that pharmacists are actively referring women for whom
over the counter EHC is inappropriate to GPs (90%) and
family planning clinics (60%). Pharmacists reported
receiving little feedback about either positive or negative
experiences with EHC.
Pharmacists supplying EHC through a community
pharmacy Patient Group Direction scheme in one area of
London were surveyed as part of the evaluation of the
programme (B3: Lambeth, Southwark and Lewisham
Health Action Zone 2002, p69). The pharmacists identified
the important role of counter staff in managing waiting
customers. They reported increased professional self-
esteem as a result of taking part in the Patient Group
Direction scheme.
Immunisation 
Relevant findings from peer-reviewed literature:
• Pharmacy patient medication records can be used for 
case-finding of ‘at risk’ clients to be invited for
immunisation and can increase the percentage of the
target group immunised (B3).
Key findings from non peer-reviewed literature:
• Pharmacy patient medication records are effective in 
identifying and flagging ‘at risk’ patients to prompt
and enable pharmacist intervention for immunisation
(B3).
A feasibility study was conducted of identification of ‘at
risk’ patients for influenza immunisation through
community pharmacies (B3: Williams et al 1993, p73). A
systematic method using pharmacy patient medication
records was effectively used to identify such patients. A
questionnaire given to those patients identified showed
that a significant percentage had not previously had
influenza immunisation. In comparison, an opportunistic
method based on the presentation of influenza-like
symptoms and purchases of relevant over the counter
medicines was less effective. The response from
pharmacists using the opportunistic method was low and
feedback suggested this was due to lack of remuneration.
26
Analysis / discussion point:
The findings from the non peer-
reviewed literature demonstrate
the high level of user and
pharmacist acceptability of the
pharmacy supply of EHC and also
the effectiveness of increased
access within the time-sensitive
period (72 hours). There is an
expressed wish from pharmacists
to be supplying more EHC under
Patient Group Direction,
particularly to those under 16
years of age and for women who
find the cost of over the counter
supply prohibitive. In addition,
pharmacy supply of EHC under
Patient Group Direction would be
likely to lead to pharmacy-based
services becoming more
integrated with other local
services and could potentially
increase referrals between major
service providers. Further
monitoring is needed into the use
of, and outcomes of, pharmacy
supply of EHC under Patient
Group Direction.
Analysis / discussion point:
The literature demonstrates the
potential effectiveness of
systematically using pharmacy
patient m medication records to
identify high risk individuals for
immunisation. It is recommended
that piloting of this system should
begin as soon as possible in the
UK.
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Head lice
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature:
• Pharmacists and health professionals appear positive 
about the service and express a wish for it to continue
(B3).
• The majority of head lice management programmes 
require proof of infestation before treatment is
supplied and between one-quarter and one-third of
consultations result in no treatment being
recommended (B3).
• Where treatment is supplied, community pharmacists’ 
adherence to the local formulary appears to be
extremely high (approaching 100%) (B3).
• User feedback shows that head lice management 
services are generally well-received, but between 18%
and 34% of scheme users report having some
concerns about privacy in the pharmacy during the
consultation (B3).
• Work is needed locally to ensure messages about 
treatment of head lice infestation are consistent
between pharmacists, GPs, practice staff and schools
(B3).
• There is some evidence that the cost of over the 
counter head lice treatments is a barrier to
appropriate use. Community pharmacy supply of
treatment on the NHS should be explored in areas
where this applies (C1).
Two reports evaluating community pharmacy provision of
head lice management were reviewed (B3: Philips et al
1999, p73; B3: National Pharmaceutical Association 2001,
p74). A total of 5710 users accessed a scheme involving
32 community pharmacies in three Primary Care Groups
in the three-month evaluation period (B3: Philips et al
1999, p73). Most consultations were on behalf of children
(76.8%) and were by females (67.4%). Almost all (94%)
of scheme users were exempt from prescription charges.
Proof of infestation was required before treatment was
supplied and no treatment was recommended in one-
third of consultations. Where treatment was supplied by
the pharmacist it conformed to the local formulary on
99% of occasions. The scheme was well received by users,
although 18% reported feeling embarrassed to discuss
head lice with the pharmacist.  GPs and school nurses
rated the scheme highly.
A total of 1847 clients accessed a community pharmacy-
based head lice management scheme covering two
Primary Care Groups and 32 pharmacies (later extended
to 47) in Sunderland during a seven-month period (B3:
National Pharmaceutical Association 2001, p74). Proof of
infestation was required for treatment and was shown in
77% of consultations, avoiding the use of chemical
insecticides in 415 cases. The scheme was well received by
users and was rated ‘good’ or better by 82% of users.
Roughly one-third said they were not able to have a
private discussion in the pharmacy. Three-quarters of
users said they intended to use regularly the head lice
comb they had been given as part of the scheme. Almost
three-quarters of GPs reported that the service had
reduced the amount of time they spent dealing with
head lice infestation. Roughly one-third of GPs reported
they ‘rarely’ (31%) or never (3%) saw the client when
prescribing head lice treatment. Over 90% of health
professionals wanted the service to continue and 66% of
GPs wanted it to be extended to cover other conditions.
Pharmacists reported that 67% of initial consultations
took between 5 and 10 minutes and 93% said they
would be happy to continue the service.
Communication to enable consistency of information
about head lice treatment was studied in a survey of
community pharmacists, head teachers of primary
schools, school nurses and GPs in one locality (B3: Thomas
2000, p75). The response rates for different groups
ranged from 65–90%. Schools were found to provide
information to parents that was sometimes out of date
and/or at odds with that being given by health
professionals. Some of the survey groups had different
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preferences for treatment types, suggesting that
recommendations would be likely to differ. Thomas
concluded that there was considerable potential for
parents to be presented with conflicting and confusing
information and identified a need to develop a
consistent approach.
In a community pharmacy-based study, staff in 34
pharmacies recorded details of requests for head lice
products on prescription and over the counter (C1:
McGovern 2001 p75). Among 184 customers who
completed a questionnaire, 69% said they intended to
repeat the treatment application and 38% said they
intended to treat the whole family or all children
regardless of whether head lice were found. Quantities
prescribed and purchased were lower than those
recommended in relevant guidelines. These findings raise
concerns that head lice treatments may not be optimally
used, with risks of treatment failure and the
development of resistance. 
Oral health
Relevant findings from peer-reviewed literature:
• Pharmacists are asked by their customers to give 
advice on oral health but training received on this
topic is variable and evidence of their interventions is
lacking (B3).
Key findings from non peer-reviewed literature:
• Opportunities for pharmacists to recommend sugar-
free medicines for children are limited as most
requests from customers are for a named medicine (C1).
• Training and participation in oral health promotion 
activities appear to increase pharmacists’ intent to try
to change users’ behaviour (C1).
• Most pharmacy customers say they believe sugar-free 
medicines are important for children (C1).
• A more proactive approach by pharmacists is required 
to maximise opportunities for oral health
development (C1).
Analysis / discussion point:
The use of community pharmacy-
based services to treat head lice
infestations appears to be well-
received by users and other health
professionals, although concerns
about privacy are expressed by a
significant minority of users. The
finding that no treatment was
provided in one-third of cases
indicates that pharmacists
followed the protocol requirement
for examination and proof of
infection. No evidence of
effectiveness of treatment, or
prevention of infestation or re-
infestation were reported in the
studies reviewed. Further
research to assess the
effectiveness and cost-
effectiveness of these pharmacy-
based interventions is required
together with the need for local
planning and co-ordination of
treatment services and messages.
In a study of community pharmacists’ attitudes and
practice relating to sugar-free medicines, baseline
interviews were followed by a pharmacy-based health
promotion campaign on this topic together with
educational events (C1: McGovern et al 1999, p76). On
re-interview, pharmacists’ attitudes towards sugar-free
(SF) medicines were more positive. Many pharmacists
reported taking part in the health promotion campaign,
participating in postgraduate education on oral health or
reading relevant articles. 
Data collection in the same study on sales of over the
counter paediatric medicines showed that most requests
were made for a named medicine and the pharmacist’s
recommendation was sought in around 15% of cases.
The percentage of pharmacists indicating they would
attempt to persuade a purchaser of a sugar-containing
medicine to switch to a SF product had increased in the
follow-up interviews. The authors noted that
improvements had occurred due to the educational and
campaign activities. They concluded that further
improvements could be made and that greater
proactivity by pharmacists would be needed (C1:
McGovern et al 2000, p76).
Mental health
Relevant findings from peer-reviewed literature:
none relevant. 
Key findings from non peer-reviewed literature: 
• Community pharmacies are used for the purchase of 
products to reduce stress and anxiety (C1).
• Most (87%) pharmacy users did not regard 
pharmacists as their preferred source of advice on
stress and anxiety (C1).
• Around half of pharmacy staff were aware of 
relevant local self-help groups (C1).
• Pharmacy users take up leaflets on topics relating to 
stress and anxiety, with leaflets on sleep problems
and relaxation being most commonly selected (C1).
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Analysis / discussion point:
There appears to be some
potential for community pharmacy
staff to be further involved in the
provision of services to promote
oral health. Some limitations on
this role, however, appear to be
linked to pharmacy user requests
for a specific named medicine that
potentially presents a conflict of
interest between the pharmacist’s
role as a health professional
versus their business interests. This
is an issue that needs to be
addressed locally through training
and remuneration of services.
Indeed, pharmacists in the study
reviewed seemed to be persuaded
by training to try to encourage
customers to purchase a SF
alternative.
Analysis / discussion point:
Although a highly-sensitive topic,
there appears to be potential for
pharmacy staff to offer support
and advice in relation to mental
health issues. At present the
majority of pharmacy-based
support appears to be linked to
medicine sales. Pharmacy users,
however, are also looking for
more information and additional
sources of help as exemplified by
leaflet uptake. In addition, some
staff have knowledge of relevant
local services but it is not clear
whether this information is easily
accessible to pharmacy users. As
pharmacists already provide and
successfully offer help on other 
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The involvement of pharmacy staff in the management
of stress and anxiety was the subject of a pilot study in
one locality (C1: Reilly et al 2001, p77). A training
evening was held, and a resource manual was produced
and distributed to all pharmacies. Pharmacy customers
were asked to complete a questionnaire on frequency of
symptoms, any treatments purchased and preferred
sources of advice; 150 did so (90% response rate). The GP
was the preferred source of advice on stress and anxiety
(76%), with friends (36%) and the pharmacist (13%) next.
However, 33% of respondents reported that they had
purchased a remedy to help their symptoms, indicating
opportunities for pharmacy staff to intervene (but
interventions, other than the sale of a product, were not
recorded). Just over half of the 24 pharmacy staff
interviewed were aware of local self-help groups and
might have been able to refer to them (although the
study did not record whether they intervened or not).
Leaflet uptake during the study ranged from 41 to 155
per pharmacy with the most popular topics being sleep
and relaxation guides. 
Prevention of transmission of infection
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature: 
• Pharmacists generally have positive attitudes towards 
involvement in prevention of transmission of
infection (B3).
• Pharmacists knowledge about transmission of HIV, 
hepatitis B and hepatitis C is variable (B3).
A survey of community pharmacists found positive
attitudes towards involvement in activities and services to
prevent transmission of HIV and hepatitis B and C (B3:
Watson et al 2002, p77). Pharmacists’ knowledge about
blood-borne diseases was found to be variable. The main
sensitive issues (e.g. emergency
hormonal contraception and head
lice management) it is feasible
that support could be extended to
mental health issues, however, the
common barriers to receiving
advice on sensitive topics
(especially privacy and
confidentiality) would need to be
addressed before further
publicising these services. In
addition, pharmacy-based services
should be integrated into other
relevant local services, further
training provided and outcomes
monitored.
Analysis / discussion point:
Pharmacists potentially have a
significant role to play in
preventing and reducing the
transmission of infections (see
also sections on Sexual health and
Immunisation), however, current
evidence suggests their
involvement is mainly limited to
opportunistic travel health advice
(see for example, Report 4).1 The
main barriers to their increased
involvement are similar to those
cited for health development
activities in general, in particular a
lack of time, remuneration and of
a private area for consultation,
however the importance of the
topic concerned and its
implications for public health are
such that further exploration and
research into their potential role is
urgently required.
1  Local Pharmacy Health Development Projects – Testing Models of Implementation in Community 
Pharmacy (2002). Unpublished work available on request from pharmacyhealthlink@rpsgb.org.uk
or 020 7572 2265.
barriers to extended involvement were perceived by the
pharmacists to be time, availability of a private area and
lack of remuneration.
Accidental injury prevention 
Falls prevention
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature: 
• A pharmacy-based osteoporosis screening service 
involving pharmacist and nurse input was found to be
feasible and identified women at risk of osteoporosis
(B3).
• Women using the scheme valued the accessibility 
offered by community pharmacy (B3).
One report of a community pharmacy-based osteoporosis
screening service was reviewed (B3: Martin-Hamblin-GfK
2002, p78). The study was a small scale pilot in one
pharmacy, where 228 women completed a risk
assessment questionnaire. Of these, 49 were found to be
low risk and the remaining 179 had a bone scan
conducted by a nurse in the pharmacy, from which 36
were found to be osteoporotic and were referred to the
GP for treatment. Most users (78%) were either invited
to take part by pharmacy staff or self-referred after
seeing a project poster in the pharmacy. While three-
quarters rated the pharmacy as a more convenient
location than their doctor’s surgery this did not
necessarily translate into intended future service use. Just
over half the women said the convenience of the
pharmacy would make them more likely to use the
service, suggesting that other factors played an
important part. Most users rated pharmacy staff as
very/extremely accessible (90%) and professional (83%).
The nurse’s input was also highly valued, with over 90%
rating as very/extremely knowledgeable and as giving
very/extremely clear explanations.
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Medicines-related injuries
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature: 
• Requests to patients to return unused medicines to 
the pharmacy result in large quantities of excess
medicines being identified (C1).
• Changes in therapy, the death of patients and adverse 
effects are important reasons why excess quantities of
medicines occur in people’s homes (C1).
• Discussions between local health professionals appear 
to be useful in making changes to prescribing
frequency to prevent the accumulation of excess
medicines (C1).
A study in which data were collected on unwanted
medicines returned to community pharmacies showed
that the main reasons for return were a change in
therapy, the death of the patient and adverse reactions
(C1: McGovern et al 2001, p78). The most commonly
returned medicines were for treating cardiovascular
conditions. The authors note that there was some
evidence of excessive prescribing. The results of the study
were subsequently discussed locally and changes in the
frequency of prescribing were agreed.
Factors affecting the effectiveness of
community pharmacy health
development activity 
Training2
Relevant findings from peer-reviewed literature: 
• Community pharmacists trained in behaviour change 
methods are effective in helping clients stop smoking
(B1).
• Training in smoking cessation techniques increases 
Analysis / discussion point:
Pharmacists and their staff have a
substantial amount of contact
with older people (who often have
a high medicines intake) and
people who require repeat
dispensing during the normal
course of their work (see section
on Public use of community
pharmacies, p41). This places them
in a good position to be able to
identify where the use of
medicines may be predisposing
the user, or carer, to accidents in
the home or elsewhere. The
review of medicines for high or
frequent users (as required by
national and local policies)
presents an ideal opportunity for
the pharmacist to initiate a
discussion with the user or carer
to identify potential risk factors
and help determine solutions to
minimise these risks. Further
research into the pharmacists’ role
in preventing accidents in other
target groups, for example
children and young people, is also
warranted.
2  See sections on Pharmacists (p44), Smoking cessation (p17), drug misuse (p19) and oral health (p29) 
for more details of studies reviewed.
pharmacists’ effectiveness in achieving higher quit
rates (B1).
• Training in skin cancer prevention enhances 
knowledge and increases the opportunistic offering
of advice to clients by pharmacists (B1).
• Training increases the length of consultation between 
pharmacist and clients on health issues (B2).
• Training in health improvement increases the time 
that community pharmacists spend in consultation
with pharmacy users and also increases user
satisfaction (B3).
• Specific training needs have been identified for 
pharmacists participating in pharmacy-based needle-
exchange schemes (C1).
Key findings of non peer-reviewed literature:
• Training has positive effects on the consultation and 
information-giving behaviour of community
pharmacy staff (B1).
• Training increases knowledge, self-confidence and 
positive attitudes of pharmacists and their staff in
relation to smoking cessation (B1).
• Postgraduate training produces positive changes in 
both attitudes and behaviour of community
pharmacists in relation to health improvement
activities (B3).
• Training for pharmacists needs to include skills in 
translating technical terms into a suitable language
for drug misusers (C1).
• Training and participation in oral health promotion 
activities appear to increase pharmacists’ intent to try
to change users’ behaviour (C1).
Use of pharmacy patient medication records3
Relevant findings from peer-reviewed literature:
• Using pharmacy patient medication records to 
34
3  See section on Immunisation (p26) for details of studies reviewed.
Analysis / discussion point:
The research evidence identifies
the effectiveness of training in
changing pharmacists’ practice
behaviours. Training also affects
pharmacists’ confidence and
attitudes and there is evidence
that pharmacists who have
undergone training will have
increased involvement in health
improvement activities. It is
therefore key to the successful
implementation of community
pharmacy-based health
improvement programmes.
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identify clients at ‘high risk’ of coronary heart disease
is an effective method of identifying those most at
risk and instigating health promotion measures (B1).
• Pharmacy patient medication records can be used for 
case-finding of ‘at risk’ clients to be invited for
immunisation and can increase the percentage of the
target group immunised (B3).
• Information routinely kept by community pharmacies 
on dispensed medication enables case-finding of
patients for interventions in lipid management (C1).
Key findings from non peer-reviewed literature:
• Pharmacy patient medication records are effective in 
identifying and flagging ‘at risk’ patients to prompt and
enable pharmacist intervention for immunisation (B3).
Design and use of pharmacy premises
Privacy,4 anonymity5 and confidentiality6
Relevant findings from peer-reviewed literature:
• Most pharmacy users perceive there is sufficient 
privacy in the pharmacy to discuss even sensitive
subjects (B2).
Key findings from non peer-reviewed literature:
• Community pharmacists and users appear to have 
different perceptions of what constitutes acceptable
facilities to maintain privacy (B3).
• Pharmacy users’ perceived concerns about privacy are 
generally not borne out in their reports of actual
experience (B3).
• Most users of potentially sensitive pharmacy services 
(e.g. emergency hormonal contraception; head lice
management) report adequate facilities for privacy in
4  In this report the definition of ‘privacy’ used is: ‘Being able, or having the facilities, to hold a
private discussion in the pharmacy at a convenient time for the client without being overheard.’
5  In this report the definition of ‘anonymity’ used is: ‘Where the client uses the pharmacy for 
advice or services with the explicit intention of remaining unidentified and/or untraceable.’
6  Pharmacists have a professional duty of confidentiality to all their clients, including not 
releasing information gained from a consultation to the client’s doctor without the client’s
express permission.
Analysis / discussion point:
Research findings show the
potential of community pharmacy
patient medication records to
identify and target specific groups
of patients. Primary care
organisations need to consider
how this potential can be
harnessed to contribute to
achieving local health targets.
community pharmacy with a consistently sizeable (up
to 20%) minority expressing concern (B3).
• A sizeable minority (up to 20%) of women obtaining 
emergency hormonal contraception from community
pharmacies reported having concerns about
confidentiality and this was higher among those
under 19 years of age (B3).
User views
The results of a self-completion questionnaire study of
users suggests that the public may have a different view
of what constitutes appropriate facilities to enable
private discussions. The researchers found that ‘two-
thirds of the respondents would like to be able to talk to
the pharmacist in private, while only 5% had found and
used such facilities to date’ (B3: Aston University/MEL
Research 1991, p79). 
In her study of the health information needs of people
buying aspirin for heart disease prevention, or receiving
it on prescription, Kinghorn concluded that ‘pharmacy
premises were considered by some to lack privacy’ (C1:
Kinghorn 1998, p65).
The most important factor for users considering a
pharmacist for advice in a study on contraception and
safer sex was the availability of a quiet area, cited by
41% of the 224 respondents (B3: Campbell Keegan 1992,
p67). Quality and confidentiality of pharmacists’ advice
were identified by users as influencing possible use of a
community pharmacy advisory service on women’s health
(B3: McAree 2001, p69).
In a large interview study with pharmacy users, one-third
said they would be willing to ask about a sensitive or
personal problem in the pharmacy. Around two-thirds
said there was insufficient privacy to discuss a sensitive
problem in the pharmacy and only 18% believed that
privacy was adequate. Women were significantly more
likely than men to say that they would discuss a sensitive
problem with the pharmacist (C1: Coggans et al 2000, p79).
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A study of user attitudes towards community pharmacy
supply of emergency hormonal contraception (EHC) prior
to deregulation from POM to P (prescription only
medicine to pharmacy medicine), or supply on Patient
Group Direction, involved 10 focus groups with women
who had used, or might use, EHC (B3: Edwards 2000,
p72). While women were positive about pharmacy supply
of EHC, the open pharmacy environment was a ‘major
concern’. The same study also found that participants
were concerned about confidentiality in the community
pharmacy setting and about what records would be kept
of the supply. It is not possible to tell from the findings
the distribution of these concerns between women who
were expressing their perceptions and those who had
used EHC. However, when pharmacy users are asked
about their actual experience rather than perceptions the
results are quite different as the results of consumer
studies conducted prior to and since wider access through
pharmacies to EHC demonstrate. 
In a study of women who had all obtained EHC from
pharmacies by Patient Group Direction, most were
satisfied with the level of available privacy, although
approximately one in five felt there was insufficient
privacy for their discussion with the pharmacist (B3:
Lambeth, Southwark and Lewisham Health Action Zone
2002, p69).  
In a national survey of womens’ experience of obtaining
EHC through community pharmacies, the setting was
highly rated as a suitable place to obtain and discuss EHC
by women receiving it on prescription, Patient Group
Direction or through over the counter purchase (B3:
Pharmacy Alliance 2002b, p71). 
These findings suggest that many women find it
acceptable to discuss this sensitive subject in a community
pharmacy. The same study found that most women did
not have concerns about confidentiality and pharmacy
supply, although roughly one-quarter of women did. 
Most (80%) women using a community pharmacy-based
osteoporosis screening service felt they were treated with
‘complete’ privacy and confidentiality, with 18%
reporting a ‘degree of privacy’ and 2% giving a negative
rating (B3: Martin-Hamblin-GfK 2002, p78).
Just over two-thirds (68%) of the 600 pharmacy
customers interviewed in a Scottish study believed their
discussions in the pharmacy would be confidential.
Women were significantly more likely than men to say
that confidentiality would be maintained (C1: Coggans
et al 2000, p79).
Two reports of community pharmacy-based head lice
management schemes included an assessment of users’
perceptions of privacy. In the first study, 17.6% of 336
users reported being embarrassed to speak to the
pharmacist about head lice (B3: Philips et al 1999, p73).
In the second study, 42% of users agreed that they were
able to discuss their problem in private, 34% said they
were not able to do this and 24% were ‘not bothered’
about this aspect (B3: National Pharmaceutical
Association 2001, p74). 
Pharmacist views
The availability of a ‘quiet area’ in the community
pharmacy to provide a setting for private discussion was
explored in several studies. In a large survey in the late
1980s, 62% of community pharmacist respondents
reported that their premises had a suitable area or room
for private discussion and one in four pharmacies
reported having a ‘consultation room’ (B3: Shafford &
Sharpe 1989, p80). 
Methods of provision of health information
Use of leaflets
Relevant findings from peer-reviewed literature:
• Awareness of pharmacy-based leaflets on health 
topics is higher for those clients taking prescribed
medicines (B3).
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Analysis / discussion point:
Feedback from pharmacy users
demonstrates that pharmacy-
based EHC and head lice
management services are highly
rated. However, although most
users report finding the level of
privacy in pharmacies acceptable,
a significant minority do not. In
addition, around one in five
women receiving EHC were
unsure whether the information
would be kept confidential. These
findings suggest that although
community pharmacists can play a
valuable role in providing these
services and believe they currently
have adequate facilities to do so,
there is a need to be aware that a
significant minority of the public
still report concerns over privacy
and confidentiality. Suggested
action to address these issues
would include reviewing the
facilities available for private
discussion in community
pharmacies and greater publicity
about the terms and conditions
for confidentiality that apply to
pharmacists and their staff.
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Key findings from non peer-reviewed literature:
• Community pharmacists consider leaflets to be an 
important component of their health improvement
toolkit (B3).
• Passive displays of leaflets may be missed by half of 
pharmacy customers (C1).
The display and use of health promotion leaflets was
included in several studies. In Shafford and Sharpes’ large
survey of community pharmacists 56% of respondents
believed leaflets to be of ‘great’ or ‘very great’
importance and 45% reported displaying them (B3:
Shafford & Sharpe 1989, p80). The findings of that study
suggested that pharmacists gave a higher priority to
displaying leaflets than to providing advice on health
education, indicating a preference for passive rather than
active involvement. However, as passive displays of
leaflets were found to be missed by nearly half of
pharmacy customers (B3: Aston University/MEL 1991,
p79), leaflet-based strategies are best viewed as
supportive of medicines or health advice, or through
offering an opportunity for further discussion, rather
than an end in themselves.
Multimedia technology
Relevant findings from peer-reviewed literature:
none relevant.
Key findings of non peer-reviewed literature:
• Multimedia technology may be a means of engaging 
young and healthy pharmacy customers in health
improvement activities (C1).
A small experimental descriptive study assessed the usage
of a multimedia touch screen kiosk in the community
pharmacy setting (C1: Hariri 1998, p81). Over 12,400
people used the kiosk in six pharmacies. Usage was much
higher in supermarket pharmacies compared with others,
however, the completion rate for the software used was
similar in the two groups at 31% and 37%. Most users
were relatively young (under 40 years) and data collected
on Body Mass Index (BMI) showed the majority to have a
‘healthy’ figure of 25 or less. Observation studies showed
that older customers needed encouragement and a
demonstration by the pharmacist before they used the
kiosk. These results suggest that younger and healthier
pharmacy customers are more willing and likely to use
computer-based information points. The low completion
rate suggests that further work is needed to develop
programmes with which this younger group will engage
more fully. The lower technology familiarity of older
pharmacy customers and their high frequency of use of
pharmacies also needs to be taken into account in
designing future strategies.
Stakeholder views
Pharmacy users 
Relevant findings from peer-reviewed literature:
• User feedback from pharmacy-based health 
improvement activities is generally very positive (B3).
• Users’ awareness of community pharmacies as a 
source of general health advice is low (B3).
• Pharmacy users report having followed the health 
advice given by pharmacists with positive views on
the pharmacist’s input (B3).
• Most users perceive there is sufficient privacy in the 
pharmacy to discuss even sensitive subjects (B3).
• Community pharmacy-based supervised methadone 
administration services can achieve high attendance
rates and be acceptable to clients (B3).
• User satisfaction with pharmacy-based immunisation 
services is high (C1).
• Users were generally satisfied with the emergency 
contraception service pharmacists provided (C1).
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Analysis / discussion point:
The means of provision of health
information to patients is rapidly
developing with the introduction
of new technologies, for example,
portable touch-screen kiosks, and
the public’s increasing access to
electronic information through the
Internet. These technologies are
also being applied to the NHS
with the introduction and
increasing use of telephone
advice-lines (e.g. NHS Direct in
England) and NHS advice and
services via the Internet (e.g. NHS
Direct On-Line). Pharmacists need
to consider what are the most
appropriate ways of ensuring their
users have access to the
information they need. This can
take a variety of forms, such as
written information, provided as
leaflets or electronically. At the
time of writing there was not
sufficient evidence to suggest that
one particular form was more
effective than another. Instead it
appears that different methods of
receiving health information
depend on individual user
preferences and characteristics.
When a pharmacist, or staff
member, actively engages with a
client about their health needs it
is possible to determine what
method of information provision
might suit them best. At other
times, neither pharmacy users nor
the pharmacist may be able, or
willing, to engage in further
consultation and at these times
the provision of easily accessible
written, or electronic, health
information should be available to
those who require it.
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Key findings from non peer-reviewed literature:
• Public use of community pharmacies is almost 
universal but is low for general health advice (B3).
• Community pharmacists are perceived as drugs 
experts rather than experts on health and illness (B3).
• Community pharmacies are highly rated by users as a 
source of supply and advice for emergency hormonal
contraception and head lice management (B3).
• The actual experience of service users appears to be 
more positive than their perceptions of access to and
value of advice and services from community
pharmacies (B3).
The public’s use of community pharmacies
Public use of community pharmacies is high, with 94% of
respondents in a large (517 adults) interview-based
survey having used a pharmacy in the previous year for
one of three core reasons: obtaining prescription
medicines; ‘over the counter’ medicines purchase; healthy
lifestyles related advice (B3: BMRB 1996, p81). The
ACORN (A Classification of Residential Neighbourhoods)
classification was used in sampling.7 Reported use was for
prescriptions (90% of respondents), over the counter
medicines (30%) and seeking general health advice
(10%). Use for general health advice was higher among
women, respondents with young children and those from
lower socio-economic groups. Respondents in the
‘striving’ ACORN group live in the poorest conditions and
correspond well with those in the ‘inner city’ group who
are the most frequent users of pharmacies. Overall 14%
of respondents reported receiving unsolicited health
advice from pharmacies. See Table 4.
7  See http://www.caci.co.uk/pdfs/acorn2001.pdf for more information on the ACORN classification.
Table 4. Use of community pharmacies by ACORN 
(A Classification of Residential Neighbourhoods)
categories 
The categories represent a decreasing socio-economic gradient from left to
right, where ‘thriving’ is more affluent and ‘striving’ is deprived.
A health diary study of health status and use of health
resources in primary care among 834 residents in 346
households found that frequency of pharmacy use was
high and mainly restricted to the prescription service (B3:
Hassell et al 1998, p82). Most people self-managed minor
conditions, with 5.5% using the community pharmacy for
advice. Interviews with a sub-sample of 41 diary respondents
found that community pharmacists were perceived as ‘a
drug expert – advising on medicines not illness’.
Pro forma diaries completed by community pharmacists
showed that only 3% of recorded enquiries were about
general health (B3: Shafford & Sharpe 1989, p80). It was
noteworthy that enquiries about general health took
longer to deal with than did those about prescribed
medicines or symptoms and also that they tended to be
made during busy dispensing periods.
Public perceptions of the pharmacist’s role in
giving health advice
Most pharmacy users in an interview survey with 592
customers in six pharmacies participating in the Barnet
High Street Health Scheme believed that the doctor was
the best and most convenient person to go to for advice
about staying healthy (B3: Anderson 1997, p82).
Although 40% of users believed that it was the ‘usual
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Usage at least 
one every 
Week to every
4 weeks
48%   35%   47%   53%  46%    57%
2 months to once 
within last year
52%   65%   53%   47%  54%    43%
Average number 
of times per year
12      10     12    12    12       14
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job’ of the pharmacist to advise on staying healthy, only
15% had ever asked for such advice. 
Interviews with 600 customers in 30 community
pharmacies in Scotland showed a clear distinction in the
proportion willing to seek advice on medicines-related
and non medicines-related topics (Table 5). When asked
why they were not willing to discuss healthy eating with
the pharmacist, two-thirds said they already knew enough
about it. However, 22% of respondents said either that they
did not see this as part of the role of community
pharmacy or that it had not occurred to them that pharmacies
could provide such advice (C1: Coggans et al 2000, p79).
Table 5.  Willingness of pharmacy customers to
discuss health topics with the pharmacist (n = 600)
Health topic Percentage of customers agreeing
Prescribed medicines 86
Minor health problems 84
Smoking cessation 66a
Sensitive topics 33
Healthy eating 32
Exercise 20
Source: Coggans et al 2000.
aOf smokers prepared to contemplate quitting
Over a quarter of the 224 respondents in a questionnaire
survey to determine pharmacy users’ views of health
information leaflets in pharmacies reported difficulty in
identifying the pharmacist and a similar proportion
agreed that ‘the pharmacist prefers to keep out of sight’.
The researchers concluded that ‘there are still many people
who are unaware of the pharmacist’s role as an adviser
on general health matters’ (B3: Aston University/MEL
Research 1991, p79). None of the respondents in a survey
of 224 users spontaneously suggested that they would go
to the pharmacist for advice on contraception or safer
sex (B3: Campbell Keegan 1992, p67).
Many of the 39 pharmacists interviewed in a qualitative
study believed that the public ‘did not recognise the
extent of their training and skills and see them as
shopkeepers, not health educators’ (B3: Anonymous
1993, p83). Pharmacists who participated in a large
questionnaire study were reported to be ‘keen for the
public to be better educated about the role of the
pharmacist in healthcare in general’ (B3: BMRB 1993, p84).
Users’ experience of advice and services in the
pharmacy setting
Several studies were identified that obtained feedback from
users about advice and services actually received, rather
than their perceptions of, or attitudes to, receiving them. 
Client feedback on the pharmacy supply of emergency
hormonal contraception (EHC) was obtained in two
studies. Women receiving EHC through a Patient Group
Direction in South London showed a high level of
satisfaction with the service (B3: Lambeth, Southwark
and Lewisham Health Action Zone 2002, p69). A high
level of satisfaction with community pharmacy supply of
EHC was also found in a national survey of women
receiving the treatment on prescription, Patient Group
Direction or purchasing it over the counter (C1: Pharmacy
Alliance 2002a, p70). Pharmacies were highly rated as a
place to obtain and discuss EHC. A desire for anonymity
was the reason why 9.7% of women surveyed had opted
for over the counter purchase of EHC.
Users who received advice on women’s health in a pilot
study in four pharmacies were reported to respond
positively (B3: McAree 2001, p69).
One study investigated the views of clients of pharmacy
drug misuse services (B3: Sheridan 1995, p66). Clients
perceived pharmacists as service providers but not as a
source of advice. Some clients reported positive experiences
of their interactions in pharmacies but others considered
themselves to be stigmatised by community pharmacists.
Pharmacists
Relevant findings from peer-reviewed literature:
• Pharmacists attach a high degree of importance to 
health improvement activities (B3).
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Analysis / discussion point:
Use of community pharmacies for
general health advice tends to be
low among the public but appears
to be higher among women,
respondents with young children
and lower socio-economic groups.
People living in areas of
deprivation, high unemployment
or in inner cities are more
frequent users of community
pharmacies.
Both the public and community
pharmacists believe that the
advice-giving role of community
pharmacists on general health
issues is not widely recognised or
utilised. As service developments
occur it may be necessary to run
local campaigns to raise public
awareness of services on offer and
to target those who would benefit
most from increased access, such
as those living in areas of
deprivation or inner cities. Further
research is required to investigate
the use of community pharmacies
by lower socio-economic groups,
particularly in relation to advice-
giving as well as the supply of
medicines.
45
• Pharmacists are more comfortable with health 
improvement activities that are related to medicines
and need support to extend their portfolio of health-
related work (B3).
• Pharmacists’ advice is more likely to be reactive than 
proactive (B3).
• Pharmacists’ concerns about being ‘intrusive’ in 
offering potentially unwelcome health advice
predisposes to a reactive stance (B3).
• Pharmacists were positive about their experience of 
providing emergency hormonal contraception (B3).
• Pharmacy staff appear positive about promoting the 
role of folic acid in pregnancy but there is no evidence
of the effects of intervention on behaviour (B3).
• Dispensing duties are widely reported as a key barrier 
to pharmacists’ greater involvement in health
improvement activities (B3).
Key findings from non peer-reviewed literature:
• Training has positive effects on the consultation and 
information-giving behaviour of community
pharmacy staff (B1).
• Community pharmacists perceive health promotion 
activity as important but tend to spend little time on
it in everyday practice (B3).
• Future roles in health improvement are largely 
perceived as medicines-related by community
pharmacists (B3).
• Community pharmacists have concerns about the 
receptiveness of GPs and patients to a greater role in
health improvement and thus proactivity is reduced (B3).
• Postgraduate training produces positive changes in 
both attitudes and behaviour of community
pharmacists in relation to health improvement
activities (B3).
Priorities for advice-giving
Several studies explored where health improvement
featured in community pharmacists’ priorities for advice-
giving. When asked whether they believe that health
promotion is important, most community pharmacists
agree. In a postal survey only 13.5% of 1330 respondents
rated health promotion as being of ‘little’ or ‘no’
importance (B3: Health Promotion Authority Wales 1991,
p83). While pharmacists perceive health promotion to be
important it was also noted that ‘pharmacists’ health
promotion role is reactive not proactive’ and that ‘the
pharmacist’s role is very much oriented towards medical
advice … health promotion happens during this process
(B3: Anonymous 1993, p83). However, the priority that
pharmacists gave to health promotion in relation to
other activities provides a different perspective. A survey
of 897 community pharmacists (response rate 58%) found
that respondents attached ‘great importance’ to advice-
giving on prescribed medicines (52%); over the counter
medicines (45%) and health education (18%) (B3:
Shafford & Sharpe 1989, p80). 
The amount of time spent by community pharmacists on
health promotion activities was estimated as 5% in one
study (B3: Anonymous 1993, p83) while around three-
quarters of pharmacists estimated that they spent
between one and three hours a week on such activities
(B3: BMRB 1993, p84).
Most community pharmacists who participated in a study
on contraception and sexual health saw their role as
‘revolving around the provision and sale of medicines’
(B3: Hughes 2000, p68). The most commonly mentioned
areas for role development in the future in the same
study were running clinics for diabetes and asthma,
managing long-term medication, pharmacist prescribing
and health promotion.
Provision of specific services
The numbers of pharmacies providing specific services
were measured in a questionnaire survey of all
community pharmacists in Wales (B3: Health Promotion
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Authority Wales 1991, p83). The returns represented 522
pharmacy premises (response rate 67% of pharmacists)
and the services provided are given in Table 6. 
Table 6. Pharmacies in Wales providing specific
services  (n = 522)
Service Provided Percentage
Pregnancy testing 59
Weight measurement 30
Sale of needles and syringes 29
Blood pressure measurement 15
Needle/syringe exchange 8
Cholesterol testing 0.3
Lung function testing 0.01
Source: Health Promotion Authority Wales 1991.
These figures provide a useful picture of activity at the
start of the last decade and show that the majority of
pharmacies were not providing any specific services
related to health improvement with the exception of
pregnancy testing.
Barriers to greater involvement
Two large postal surveys (B3: Health Promotion Authority
Wales 1991, p83; B3: BMRB 1993, p84) provided
quantitative data on community pharmacists’ perceived
barriers to extending their involvement in health
improvement (Table 7).
Table 7.  Barriers cited by community pharmacists
to greater involvement in health improvement
Health Promotion 
Authority Wales 1991 BMRB 1993
(n = 724) (n = 1330)
Finance 54% 84%
Time 66%
Public apathy 34%
Relationship with GPs 31%
Lack of knowledge 22%
Availability of finance and time-pressures were
commonly-perceived barriers that also featured in the
peer-reviewed evidence (Report 1). The Welsh data
demonstrated pharmacists’ concerns about the
receptiveness of the public and of doctors to their health
promotion activities. Perceptions of customers’ response
to health promotion advice were explored in a large
qualitative study involving eight discussion groups and 18
individual interviews with community pharmacists (B3:
Hughes 2000, p68). Pharmacists were typically not
proactive in health promotion, feeling that they could
only respond to customer queries rather than initiating
discussions on health. Raising health promotion issues
with most clients was seen as ‘highly problematic’ as the
pharmacist had no way of knowing who might
appreciate the advice and who might be offended (B3:
Hughes 2000, p68).
Education and training
Undergraduate and pre-registration training
At the end of the 1980s pharmacists perceived that their
undergraduate and pre-registration training had not
prepared them sufficiently for a role in health
improvement. Almost three-quarters of community
pharmacists reported that their undergraduate education
gave them ‘no’ or ‘poor’ training in advice-giving on
health education topics (B3: Shafford & Sharpe 1989,
p80). In relation to pre-registration training, 48% of
community pharmacists stated that their training had
provided them with ‘no’ or ‘poor’ training in advice-giving
on health education (B3: Shafford & Sharpe 1989, p80).
An educational intervention with pharmacy undergraduates
was shown to have a positive effect on knowledge about
drug misuse and HIV but a lesser effect on attitudes
towards providing services (B3: Sheridan 1995, p66).
Postgraduate training
A questionnaire survey of 100 community pharmacists
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Analysis / discussion point:
Pharmacists’ attitudes to their role
in health promotion
Although the majority of
pharmacists rate their role in health
promotion as being important,
current activity levels are low due
to a reported combination of
barriers including lack of
remuneration, time-pressures and
perceptions of a negative response
to these activities by GPs and the
public. However, a more recently
conducted UK survey of current
activity (Report 4)8 has revealed an
explosion in local community
pharmacy health improvement
projects being run in conjunction
with NHS primary care
organisations in the following areas:
• smoking cessation;
• sexual health;
• drug misuse;
• prevention of heart disease;
• diabetes awareness;
• obesity and weight reduction;
• accident prevention;
• travel health;
• winter pressures,
e.g. immunisation awareness;
• miscellaneous, e.g. campaigns 
specifically targeted at ethnic
minority group, mental health
promotion.
Further evaluation of these services
(including means of remuneration
and time spent in these activities)
is necessary to accurately
determine the extent to which
these reported barriers exist today.
8  Local Pharmacy Health Development Projects – Testing Models of Implementation in Community. 
Pharmacy (2002). Unpublished work available on request from phs@rpsgb.org.uk; 020 7572 2265.
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(response rate 66%) found that just over half (53%) had
undertaken training in health promotion and overall
86% said they would be willing to undertake further
training (B3: Dewsbury-Mason 1998, p84).
Pharmacists who received training as part of their
participation in a health promotion programme (High
Street Health, HSH) expressed a desire to spend less time
dispensing prescriptions and more time advising
customers. Training appeared to have resulted in
pharmacists taking a more holistic view of health (B3:
Anderson 1997, p82) an approach that is not generally
predominant among community pharmacists without
training (B3: Dewsbury-Mason 1998, p84). In addition,
covert research on the HSH scheme showed that
participating pharmacists spent significantly longer with
clients consulting on smoking cessation and that they
used leaflets more proactively (B3: Anderson 1997, p82). 
Pharmacists in a focus group study were reported to be
‘poor’ at identifying their own training needs in relation
to the supply of EHC (B3: Seston et al 2000, p72), for
example, participants expressed concerns about ‘clinical’
issues but these were generally ill-defined. There was an
identified need for training in how to conduct
consultations for emergency contraception in a non-
judgemental way. The need for training on EHC supply to
focus on consultation skills rather than technical
information was also found in a large qualitative study of
community pharmacists (B3: Hughes 2000, p68). 
In a study of the effect of training on smoking cessation
advice, most pharmacy staff reported that the training
had led to a change in their consultations with customers
(B1: Sinclair 1997, p65). Pharmacy teams that had
received training were not only significantly more
knowledgeable about smoking cessation but also
significantly more confident and positive about outcomes
than were controls (B1: Sinclair 1997, p65). In addition,
customers rated their discussions more highly with
pharmacy staff from the intervention group.
Education and training of
pharmacists in preparation for a
health improvement role
Although pharmacists have
reported their undergraduate and
pre-registration training carried out
in the late 1980s as being ‘non-
existent’ or ‘poor’ in preparing
them for an advice-giving role, no
recent data to allow comparisons
with the current situation was
identified during the investigation
for this report.
In contrast, however, pharmacists
who have received post-graduate
training in health improvement are
significantly more positive in
relation to their advice-giving role
and expected health outcomes but
these findings should be
interpreted cautiously as it is likely
there is a ‘self-selection’ effect.
There are, however, significant
benefits to be obtained for both
pharmacist providers and
pharmacy users when pharmacists
undertake specific training in
External stakeholders
Relevant findings from peer-reviewed literature:
none relevant.
Key findings from non peer-reviewed literature:
• The extent of sustained joint working between 
community pharmacists and other members of the
primary health care team is generally low but may be
improved by joint training (B3).
• Primary health care team members expressed some 
general anxieties about the wider role of community
pharmacy in promoting health but reported having
confidence in individual pharmacists known to them
(B3).
• New community pharmacy service developments such 
as EHC and head lice management were well-received
by primary care health professionals (B3).
Extent of pharmacist involvement with primary
health care teams
The extent of joint working between community
pharmacists and other primary health care team (PHCT)
members was explored using a mix of quantitative and
qualitative methods in three studies. In a postal survey of
373 community pharmacists (response rate 78%) 14% of
respondents reported regular meetings with PHCT
members, and participation in collaborative projects or
initiatives was reported by 13% (B3: Elliott 1996, p84).
Some respondents commented that they had wished to
take part but had not been invited to collaborate,
indicating a reactive stance. Isolation from other health
professionals was widely reported in a study of barriers
and opportunities to community pharmacists’ wider
involvement in contraceptive and sexual health advice
(B3: Hughes 2000, p68). In a study of advice on women’s
health issues, referrals from community pharmacists to
other health professionals were found to be significantly
related to a knowledge of local referral procedures and
opening hours (B3: McAree 2001, p69).
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Data from interviews with pharmacists reporting joint
working in Elliott’s (1996) study suggested that the
survey results overestimated the amount of collaboration
and teamworking. Of 15 pharmacists who reported such
collaboration, 10 had established continuous joint
working, while in the other five cases it was minimal or
intermittent. It was noteworthy that pharmacists
dispensing higher numbers of prescriptions were more
likely to report collaboration. Close proximity to a GP
surgery with no other pharmacies close by was also
associated with collaborative work. Interviews with
Health Authority Pharmaceutical Advisers showed them
to have a key role in organising local initiatives but that
such projects were for ‘limited time periods, with limited
funding and inadequate evaluation and generally
involving an enthusiastic minority of pharmacists’ (B3:
Elliott 1996, p84).
Effect of joint learning events with PHCTs
Local multidisciplinary health improvement workshops for
PHCT members that community pharmacists were invited
to attend were evaluated prior to and following their
delivery in a commissioned report (B3: Scott 1994, p85).
Nine teams, each centred around one general medical
practice, took part in the workshop. Interviews with over
40 participants were conducted pre-workshop, then at
one week and three months post-workshop. Although
PHCT members expressed confidence in individual
pharmacists they often stated general concerns about
community pharmacy in relation to possible wider roles.
The key concerns were around community pharmacists’
lack of access to patients’ full medical history and about
potential conflicts of interest arising from commercial
activities. Nevertheless PHCT members were
predominantly positive towards pharmacists’
involvement. The community pharmacists themselves
were pleased to have been invited to participate in the
workshop but expressed anxieties about what they
would be able to contribute and about how their
presence would be received by PHCT members. This
professional reticence contrasted with the attitude of
Analysis / discussion point:
• Pharmacists report isolation 
from other health
professionals as one of the
barriers to developing sexual
health services.
• Referrals from pharmacists to 
other health professionals are
higher where pharmacy staff
have knowledge of relevant
local services.
• Collaborative working is 
reported to be higher where
the pharmacy dispenses high
numbers of prescriptions or is
the only pharmacy near a GP
surgery. This suggests that
collaborative working is
currently associated with the
existing mode of remuneration
for pharmacy services.
• PHCT members are generally 
positive about pharmacists’
involvement in service
development, however,
reservations exist around
community pharmacists’ lack
of access to patients’ full
medical history and about
potential conflicts of interest
arising from commercial
activities.
• Joint training events between 
pharmacists and PHCT
members appear to be useful
in promoting collaborative
working but pharmacists
report finding it difficult to find
time to leave the pharmacy
and attend ‘team meetings’.
PHCT members, most of whom welcomed the idea of
pharmacist participation. Three months after the
workshop there was evidence of greater contact between
pharmacists and the PHCT through specific joint events
and the issuing of invitations by almost all the practices
to the community pharmacists to attend practice
meetings. However, attendance by pharmacists was
reported to be low due to difficulties in making
arrangements to leave the pharmacy premises.
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4  DISCUSSION
Scope and quality of the material
A substantial number of studies (37) met the criteria for
the review, representing considerable investment of
resources by those conducting and commissioning the
research. The scale of the research ranged from small
local studies to national surveys and the quality of most
studies was reasonable to good. A range of
methodologies was used and the non peer-reviewed
literature was particularly rich in qualitative studies with
pharmacists and users. Low response rates to surveys or
requests to participate in interviews was the most
common reason for a study to be excluded from the
review. It is noteworthy that most of the research with
pharmacy users was based on convenience samples,
hence these studies were graded as C1, although the
quality of other aspects of the research was high and the
studies would otherwise have merited a higher grading.
Given the methodological challenges of seeking to
construct a systematic sample of a population of service
users it seems reasonable to accept that convenience
samples might be considered adequate. 
Some of the studies identified may have undergone a
form of peer review process, especially commissioned
research (although none of the reports considered made
reference to such review). The research undertaken and
submitted for higher degrees will have been subject to a
form of peer review through the internal academic
supervision process and assessment by internal and
external examiners. Nevertheless little of this work found
its way into the peer-reviewed literature. This body of
work can help to inform the pharmacy profession and
healthcare commissioners about the future development
of community pharmacy-based services.
Where does the non peer-reviewed
literature support the findings of the
peer-reviewed literature?
The non peer-reviewed literature supports the findings
from the peer-reviewed literature in several main areas.
Firstly, that community pharmacists are viewed by the
public as experts who advise on medicines rather than
health and illness. Secondly, that training has the
potential to change community pharmacists’ behaviour
and orientate their practice towards effective health
improvement activities. Thirdly, that the use of patient
medication records to identify pharmacy users ‘at risk’ of
certain illnesses can be a very effective way to identify
and persuade this group to attend for consultation or
treatment. Fourthly, that the community pharmacy
environment seems to be an appropriate setting to
deliver certain health interventions including smoking
cessation, the prevention of coronary heart disease
(CHD), immunisations and the supply of emergency
hormonal contraception (EHC). Finally, that pharmacists
report being reluctant to proactively offer health advice
lest it be unwelcome to the client but are more likely to
advise on general health issues if medicines are involved.
What new evidence does the non peer-
reviewed literature contribute?
The non peer-reviewed literature provides new evidence
on community pharmacists’ public health role in relation
to the primary health care team and on user and
pharmacist perspectives of sensitive health topics such as
EHC supply, head lice management and drug misuse
services. These findings are important because they
demonstrate the acceptability to pharmacy users of
seeking and receiving advice on sensitive health topics
within the community pharmacy setting. Evaluations of
the head lice programmes sought feedback from other
health professionals and demonstrated that GPs and
school nurses rated these services highly and wanted
them to continue. 
The non peer-reviewed literature also provided further
evidence of both pharmacy users’ perceptions of, and
their feedback on, actual pharmacy services. The data
demonstrated the difference in reported perceptions of
those who have not consulted a pharmacist about a
sensitive topic and the experience of those who have.
People who have used pharmacy services for health
development consultations (including sensitive health
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issues) have a higher level of comfort about privacy and
confidentiality than those who have not.
In addition, the non peer-reviewed literature highlights
that pharmacies are frequently used by people living in
deprived areas and who are less affluent. Community
pharmacies have the potential to contribute to reduction
in health inequalities because they are regularly accessed
by those who are most likely to have poor health chances.
Health topics
The search of the non peer-reviewed literature revealed
additional health topics that had been provided in a
community pharmacy-based setting and had been
sufficiently evaluated for inclusion in this review. Topics
included: sexual health; head lice management; mental
health; the prevention of transmission of infection; and
injury prevention. More details on each health topic is
provided in the Results section.
Factors affecting the effectiveness of
community pharmacy-based activities to
improve health
Several studies showed that some pharmacy users
expressed concerns about the level of privacy in
community pharmacies and that a pharmacy might be
selected, or deselected, depending on the facilities for
private discussion. This was found to be particularly
important in research on consumer attitudes to pharmacy
advice on contraception and sexual health. The results of
surveys of women who obtained EHC from community
pharmacies were positive overall but indicate that for
some pharmacies there is a need to review facilities, with
approximately one in five women perceiving insufficient
privacy. Similarly, studies of head lice management
services showed that some users expressed concerns
about the level of privacy during their consultation.
Pharmacists can use this feedback to review how and
where discussions are held in the pharmacy.
User perceptions of confidentiality were explored in
studies on EHC and osteoporosis screening. The findings
suggest that publicity about the requirements for
pharmacists and their staff to maintain confidentiality
may also be needed so that pharmacy users are more
aware of the pharmacist’s obligations to ensure both
privacy and confidentiality where appropriate. It is also
possible that user perceptions will change over time as
more pharmacies are refitted with provision for a
consulting room or an obvious ‘quiet area’, or because
pharmacies providing these facilities are preferably
selected by users.
Interestingly, there is some evidence of a gap between
pharmacists’ and users’ perceptions of what might
constitute ‘privacy’ in the pharmacy. While some health
topics are perhaps more obviously sensitive (e.g. EHC)
and may require a lot of privacy, pharmacists may see
some other topics as ‘routine’ and not necessarily
needing such sensitive management (e.g. head lice
treatment). Further research is needed to address this
issue and also track any changes in premises
development and the resulting use of pharmacies.  It is
possible that user surveys recommended in the
implementation of clinical governance could also provide
direct feedback to pharmacists and their staff.
Stakeholder views
User perceptions of community pharmacists
A common theme reported by users was that although
they had often identified specific information needs they
did not generally perceive the pharmacist as a source of
health advice. Instead users tended to cite the GP as the
key source of health information and advice but,
nevertheless, they perceived the pharmacist as a highly
appropriate source of advice about the use of aspirin in
CHD prevention and welcomed the increased
convenience and access resulting from deregulation of
the supply of EHC. These findings suggest that users are
more likely to accept the community pharmacist’s role as
health adviser, at least initially, when related to
medicines supply. 
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Community pharmacists’ perceptions of their
advice-giving role
Pharmacists also have concerns about doctors’ views of
their involvement in health improvement. These are
important barriers to opportunistic health improvement
activities and involvement in wider service provision.
Given the sensitivity of certain health topics, such as
sexual health and obesity management, it is
understandable that pharmacists might prefer to take a
reactive rather than proactive role on these issues,
however in other areas, such as heart disease prevention,
the non peer-reviewed research suggests that users
would already welcome information and advice from the
pharmacist. Promotion of the pharmacist’s role in
information giving to the public was suggested by
pharmacists, in some studies, as a strategy to increase
utilisation of the pharmacist’s advice.
Community pharmacists and external stakeholders
The non peer-reviewed literature provides new evidence
on pharmacists’ health improvement role in relation to
the primary health care team. Research conducted in the
mid-1990s suggested low levels of collaborative working
between community pharmacists and other members of
the primary health care team. The findings suggested
that only 10% of community pharmacists had sustainable
joint working underway with local GPs. Multidisciplinary
workshops were shown to increase shared understanding
of the contribution that community pharmacists might
make to health improvement as part of the primary
health care team and to lead to an increase in joint
working three months later. Pharmacists themselves were
reticent about what contribution they might make to
improving health within this framework. Research
showed that low awareness among community
pharmacists of local support groups and other agencies is
likely to be a barrier to increasing referrals from the
pharmacy to non-primary care services. 
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5  CONCLUSIONS
The non peer-reviewed literature strengthens the review
of evidence by confirming the key findings of Report 1
(the peer-reviewed literature), by adding new material
on health topics and on the relationships between
community pharmacists and the primary health care
team, and by providing further insights into pharmacist
and user attitudes and behaviours.
There is a high degree of expressed interest among users
in the availability of further information and advice from
pharmacists, although the pharmacist is not seen as a
primary source. The research findings suggest
considerable scope for joint working of pharmacists,
users and healthcare commissioners to develop
pharmacies as a local and accessible advice point
complementary to existing services.
Since the review was conducted the modernisation of the
NHS has continued at pace. Following announcements
for structural reform and the devolution of decision-
making to a more local level, there is a willingness to
pilot new ways of working to improve access and quality
of services and release a plethora of opportunities to
develop community pharmacy services in order to suit the
needs of the local population and to integrate more
closely with existing NHS services. It is possible that the
level of joint working between community pharmacists
and the primary health care team will already have
increased as a result of recent initiatives, such as the
implementation of Patient Group Directions for
emergency contraception and the development of
smoking cessation services. In addition, increasing
numbers of community pharmacists are undertaking
session work with local GP practices for prescribing and
medication review purposes. It will be important to
continue to track progress in this area and to ensure the
integration of the community pharmacist into the
primary health care team and local community from the
perspective of health improvement.
Further research is also needed to measure any change in
the public’s perception of the pharmacists’ role in health
improvement. Evaluation of innovative approaches to
services and premises development will also be crucial to
informing service design to meet the needs of users, and
particularly in relation to queries about approaching the
pharmacist for general health advice and addressing
perceptions about privacy and confidentiality.
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Appendix 1. National Service
Frameworks: categorisation of evidence
The Department of Health categorises individual studies
according to the standard classification set out in its
National Service Frameworks:
Evidence from research and other professional literature
A1 Systematic reviews which include at least one 
randomised controlled trial (RCT) e.g. systematic
reviews from Cochrane or NHS Centre for Reviews
and Dissemination.
A2 Other systematic and high quality reviews which 
synthesise references.
B1 Individual RCTs.
B2 Individual non-randomised, 
experimental/intervention studies.
B3 Individual well-designed non-experimental studies, 
controlled statistically if appropriate. Includes studies
using case control, longitudinal, cohort, matched
pairs or cross-sectional random sample
methodologies, and well-designed qualitative
studies, well-designed analytical studies including
secondary analysis.
C1 Descriptive and other research or evaluation not in B 
(e.g. convenience samples).
C2 Case studies and examples of good practice. 
D Summary review articles and discussions of relevant 
literature and conference proceedings not otherwise
classified. 
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Appendix 2  Details of reviewed evidence
The abstracted papers are listed by health topic in the order the
findings are included in the ‘Results’ section of the report.  Each
paper has an evidence grading (see ‘Introduction – Criteria for
inclusion of evidence’ and Appendix 1 for an explanation of the
categorisation of grade used). 
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Title, authors, source type, year and evidence
grading  Sinclair HK. 
Community pharmacy and smoking cessation:
training in behavioural change. PhD thesis,
Department of General Practice and Primary Care,
University of Aberdeen (1997).  B1
Objectives  To develop and evaluate a training
package for community pharmacists and their
assistants to improve the counselling in smoking
cessation provided in community pharmacies.
Study design  Randomised controlled trial
(randomised by pharmacy to intervention and
control). Interviews to gain insight into the
pharmacy support process. Intervention pharmacists
and pharmacy assistants were invited to attend a
two-hour training session. Outcome measure was
self-reported smoking cessation rates of the two
groups at one, four and nine months. A sub-
sample of pharmacy customers (25 intervention;
25 controls) were interviewed by telephone six
months after registration. Pharmacists completed a
questionnaire immediately after training and 2
and 12 months later. Telephone interviews were
conducted with 20 pharmacy personnel.
Sampling and response rate  All 76 non-city
Grampian community pharmacies were invited to
Title, authors, source type, year and evidence
grading  Kinghorn IA.
The health education needs of patients buying or
receiving aspirin on prescription for
thromboprophylaxis. MSc thesis, Department of
Medicines Mamagement, Keele University (1998).
C1
Objectives  To establish the reason for
purchase/prescription of aspirin; assess the
patient’s knowledge of aspirin’s use and mode of
action in coronary heart disease (CHD) prevention;
assess patients’ knowledge of CHD risk factors;
participate and 62 (82%) agreed. All intervention
pharmacies were represented at the training (40
pharmacists and 54 assistants).
Key findings  Pharmacy personnel thought the
stage of change model was a good way of
understanding stopping smoking. Most reported
that the training had made a difference to the
way they counselled customers. At 2 and 12
months the intervention pharmacy teams were
significantly more knowledgeable, self-confident
and positive about the outcome of pharmacy
counselling than controls.
Customers (224 intervention; 268 controls) were
recruited to the study. Significantly more
intervention subjects were not smoking at each
follow-up: one month 37% cf. 29%; four-months
20% cf. 13%; nine-months 12% cf. 7%. Statistical
analysis showed these findings to be robust to
confounders (sex, age, deprivation, nicotine
dependency). Cluster randomization was found to
have a negligible effect. Intervention respondents
were significantly more likely to have discussed
stopping smoking with pharmacy personnel (85%
cf 62%). Intervention subjects rated their
discussion more highly, 34% cf 16% of controls
rated it as ‘very useful’.
identify key information needs of patients in
relation to aspirin; establish the acceptability of
advice about aspirin in the pharmacy and patients’
preferred content and format of advice.
Study design  Telephone survey using a pre-
piloted structured interview schedule (mean 23.2
minutes). Patients buying or receiving aspirin on
prescription were recruited from six community
pharmacies from a range of socio-economic
locations in Glasgow.
Sampling and response rate  Of 148 individuals
who were approached to take part, 128 (91.4%)
SMOKING CESSATION
CORONARY HEART DISEASE – THE USE OF ASPIRIN IN PREVENTION
Health Topics
agreed. Of these the researcher was able to
contact 108 during the study period. 
Key findings  70 (64.8%) respondents received
their aspirin on prescription and 38 had purchased
it. Most respondents were taking aspirin for
secondary prevention. Information needs were
identified in relation to both aspirin and CHD
Title, authors, source type, year and evidence
grading  Sheridan J.
HIV/AIDS and drug misuse: Perspectives of
pharmacy undergraduates and pharmacists. PhD
thesis, University of London (1995).  B3
Objectives  To investigate attitudes and
knowledge of pharmacy undergraduates and
community pharmacists of HIV/AIDs and drug
misuse; to investigate community pharmacists’
practice in relation to drug misuse and harm
reduction services; to investigate clients’ views on
community pharmacy services for drug misusers.
Key findings  Pharmacy undergraduates were
found to have positive professional opinions, but
also to hold some negative personal opinions
about HIV and drug misuse. An educational
Title, authors, source type, year and evidence
grading  Matheson C.
Community pharmacy services for drug misusers: a
study of the perspectives of service users and
providers. PhD thesis, University of Aberdeen
(1999).  B3
Objectives  To investigate the effect of
pharmacists’ attitudes to drug misusers on the
services provided and how services are delivered as
perceived by the pharmacist and the drug misuser.
Study design  Four methods were used. A
structured postal questionnaire collected
quantitative data from all community pharmacy
managers in Scotland on their attitudes towards
and level of involvement in service provision for
drug misusers (n = 1041). Telephone interviews
were conducted with a sub-sample of 45
pharmacists to obtain in depth information. Face-
to-face interviews with 124 drug misusers were
prevention. The pharmacist was considered highly
appropriate as a source of advice on both aspirin
and CHD but pharmacists were not considered to
be providing this service currently. Pharmacy
premises were considered by some to lack privacy.
Personal input from the pharmacist was considered
important in information provision.
intervention was shown to have a significant
positive effect on knowledge but a less noticeable
effect on attitude.
Over half of the community pharmacists were
dispensing controlled drugs to drug misusers and
13% were providing needle exchange. Community
pharmacists, like undergraduates, had positive
professional attitudes and some negative personal
attitudes towards drug misuse. The latter tended
to be more negative, indicating that practice
experience may have an effect.
Drug misusers considered themselves to be
stigmatised by community pharmacists, although
some reported positive experiences. Clients
perceived community pharmacists to be service
providers but not a source of advice.
conducted in four cities and adjacent rural areas.
Observation of interactions between drug users
and community pharmacists was conducted and
field notes taken. 
Sampling and response rate  Questionnaire
response rate: 79%.
Key findings  Controlled drugs were dispensed to
drug misusers by 61% of respondents. Methadone
was dispensed by 55% and methadone
administration was supervised by 19%. Positive
attitudes were associated with higher levels of
service provision. Pharmacists were motivated to
provide services by a desire to reduce the spread of
blood-borne diseases and to expand their
professional services. Barriers were concerns for
the effect on other customers, safety, workload
and inadequate remuneration.
Drug misusers perceived providing clean injecting
equipment and methadone dispensing as
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important services. Drug misusers asked
pharmacists for advice on general health and few
asked for advice related to drug misuse. Being
treated discreetly and having a good relationship
with the pharmacist/staff encouraged service
uptake. Negative treatment promoted
stigmatisation and precipitated negative
behaviour.
Title, authors, source type, year and evidence
grading  Scott J.
Development, implementation and evaluation of
harm reduction techniques for drug misusers.
PhD thesis, Robert Gordon University (2000).  C1
Objectives  To explore the provision of a
pharmacist-led information and advice service at a
voluntary sector drugs agency.
Study design  Field study monitoring the role of
a pharmacist within a voluntary sector drugs
service. Members of the public and other external
contacts could access the service one 3-hour
afternoon session each week when the pharmacist
was present in the agency. Drug agency workers
had telephone access to the pharmacist
throughout working hours.
Key findings  A total of 77 contacts were made
with the pharmacist during the 26 weeks that the
service was in operation. Of the 77 contacts, 45
were with Drugs Action workers, 25 with members
of the public and seven with workers from outside
organisations. 
Title, authors, source type, year and evidence
grading  Campbell Keegan.
Ask the pharmacist: advice on safer sex and
contraception. Report commissioned by Pharmacy
Health Care Steering Group (1992).  B3
Objectives  Examine pharmacists’ views on their
role on advising on safer sex and contraception;
explore views on development and support needs
for this role; investigate consumer views on
pharmacists as an information source on safer sex /
contraception.
Study design  Structured interviews with
pharmacists (telephone) and consumers (face-to-
The author concluded that remuneration,
professional endorsement and better
communication with other services would
encourage pharmacists to provide services
identified by drug misusers, such as greater
availability of injecting equipment.
Members of the public were asked if they might
consider asking the community pharmacist about
their query and most said not. The non-
judgemental attitude associated with the drugs
agency and its staff was cited as the main reason
why the query had been made there.
Drug information was the commonest type of
query (37% overall, numbers slightly higher about
prescribed than non-prescribed drugs). Drug
testing was the next commonest (15%). About half
the queries were answered using pharmacy ‘core’
knowledge, a quarter with ‘specialist’ knowledge
and a quarter with both. The key specialist skill
required was translating technical information into
terms used in the ‘drug culture’.
Other comments  The findings indicate that
there is a role for pharmacist query answering
within drugs agencies. Some specialist knowledge
was required. Client attitudes appear to be an
important barrier to information and advice-
seeking in community pharmacies.
face). Qualitative telephone and face-to-face
interviews with sub-sample of respondents.
Sampling and response rate  ‘Clustered random
sample of pharmacies across the UK’. Four regions:
north; south; Wales; Northern Ireland. Of 168
pharmacists who were approached, 104 (62%)
participated in the telephone interview; 63%
worked for independents and 36% for chains.
Qualitative interviews were conducted with 13
pharmacists. 224 consumers took part in the
quantitative interviews (49% male, 51% female).
Qualitative interviews were conducted with 17
consumers. 
SEXUAL HEALTH
Key findings  Of the pharmacists interviewed,
86% thought that pharmacists have an important
role in promoting safer sex / contraception and
53% thought pharmacists should do more in this
area. However, most (73%) pharmacists reported
being asked for advice on contraception less than
once a week. The researchers state that
pharmacists generally took a reactive role,
providing advice when asked.
64% of consumers said they would like more
Title, authors, source type, year and evidence
grading  Hughes K.
Pharmacists and contraceptive and sexual health
issues: qualitative research to inform of barriers
and opportunities. Report for Health Education
Authority (2000).  B3
Objectives  Explore barriers and opportunities
around pharmacists working with contraceptive
and sexual health issues. To explore pharmacists’
current knowledge and experience in sexual
health; to investigate attitudes towards giving
advice and information on general health and
sexual health; to consider support needs; to
explore issues around pharmacy involvement in
the provision of emergency hormonal
contraception.
Study design  Group discussions with five to six
pharmacists plus individual interviews.
Sampling and response rate  Eight discussion
groups and 18 interviews. Pharmacists were
excluded if they disagreed with the statement ‘I
feel that pharmacists have an important role to
play in improving the health of the general public
and promoting healthy lifestyles’. There were two
groups for each of: independents; independent
chains; large chains; supermarkets. Four groups
were of pharmacists qualified for up to five years;
the remainder for five or more years.
Key findings  Most participants saw their role as
‘revolving around the provision and sale of
medicines’, advising people on how to take
medicines, and responding to queries about
symptoms and how best to treat them. Ways in
which pharmacy might evolve in the future that
were mentioned most often were running clinics
for diabetes and asthma, managing long-term
medication, pharmacist prescribing and health
promotion. Promoting the clinical and wider skills
advice on contraceptives / safer sex from the
pharmacist. The most important factor in
considering a pharmacist for advice was a quiet
area (41%). No one spontaneously suggested they
would go to the pharmacist for advice on safer sex
or contraception, 38% saying they would go to
their GP. However, on probing 30% reported
having gone to the pharmacist for advice on
contraception at some time in the past.
of pharmacists to the public was seen as desirable.
Participants thought that pharmacy had been left
behind in relation to nurse prescribing, smoking
cessation services and other health promotion
areas. Pharmacists were isolated from other health
professionals and each other. People did not
typically ask pharmacists about general health issues.
Pharmacists were generally not proactive in health
promotion. They felt they could only respond to
customer queries and ‘raising health promotion
issues with most clients was regarded as highly
problematic’. There was no way of knowing who
might appreciate the advice and who might be
offended.
Health promotion activity was more likely to be
formalised in larger chains.
The potential conflict of interest was raised where
health promotion advice might not require the
purchase of a product. While most pharmacists
thought that providing the right advice led to
benefits in the long term, there was discussion
about the losses and gains in becoming more
involved in health promotion.
Across the sample, involvement in sexual health
promotion was limited and entirely as a result of
customer queries. There was general agreement
that expanding the role of pharmacists in this area
was likely to be problematic. Many participants
felt uncomfortable about this area of advice. A
private area was seen by most as essential. When
discussing EHC however participants generally saw
more scope for involvement. There was support for
deregulation of EHC, which was seen to offer more
involvement in ‘prescribing’, increase pharmacists’
status and provide a business opportunity.
Concerns were expressed about liability, ethical
issues and potential abuse. Training needs were
felt to around consultation skills rather than
clinical information. 
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Title, authors, source type, year and evidence
grading  McAree DP.
Women’s health: community pharmacy care. PhD
thesis abstract, School of Pharmacy, Queens
University of Belfast (2001).  B3
Objectives  To evaluate community pharmacists’
knowledge, attitudes and competency in relation
to women’s health; to introduce and evaluate a
pharmacy-based advice service for women.
Study design  Pharmacists’ knowledge was
measured at baseline and following a distance
learning course using a postal questionnaire. A
postal questionnaire measured pharmacists’
attitudes towards providing advice on women’s
health. 521 female Boots pharmacy customers
were interviewed face-to-face by a pre-registration
graduate to identify health issues of importance to
women and to ascertain their opinions and
reservations on aspects of a dedicated pharmacy-
based service. Pilot study in four community
pharmacies.
Sampling and response rate  Of 350
pharmacists, 216 responded to the pre-course and
133 to the post-course test.
Response rate was 273 (47.5%) completed
Title, authors, source type, year and evidence
grading  Lambeth, Southwark and Lewisham
Health Action Zone.
A timely service: Lambeth, Southwark & Lewisham
Health Action Zone project on access to emergency
hormonal contraception through accredited
community pharmacies. Lambeth, Southwark &
Lewisham Health Action Zone (2002). Report.  B3
Objectives  To assess the knowledge and
experience of users of the emergency hormonal
contraception (EHC) Patient Group Direction (PGD)
scheme.
Study design  Questionnaire distributed to 1558
service users at the community pharmacies. The
questionnaire covered user satisfaction and
included opportunities for qualitative comments.
Four qualitative interviews with service users to
validate context. Individual and group interviews
with participating pharmacists.
questionnaires from a valid random sample of 575. 
602 questionnaires were distributed, 521
completed and 81 refusals (response rate: 86.5%). 
Pharmacist feedback from feasibility study was
obtained through a seminar.
Key findings  Of 350 pharmacists, 38 had
completed the distance learning course and
showed significant improvement in test scores. The
attitudinal survey showed that pharmacists
reported they were not embarrassed to discuss
many women’s health issues. Some concerns were
expressed about confidence and knowledge
deficits. Male pharmacists perceived themselves as
significantly less knowledgeable or more
embarrassed on a number of issues. Pharmacists’
referral to other professionals was significantly
related to their knowledge of opening hours and
referral procedures.
The customer survey identified a number of factors
that might influence use of a pharmacy advice
service including quality and confidentiality.
Pharmacists in the pilot study documented
improvement in competency and knowledge.
Clients were reported to respond positively to the
service.
Sampling and response rate  Response rate:
20% (315).
Key findings  Of the service user respondents
98% reported being ‘satisfied’ or ‘very satisfied’
with the service and 90% said they felt
‘comfortable’ or ‘very comfortable’ discussing their
request with the pharmacist. 78% felt there was
sufficient privacy for their discussion and 76%
reported no concerns about confidentiality.
Concerns about confidentiality were higher in
those under 20 years of age. Roughly 20% of
respondents had concerns about privacy and/or
confidentiality.
Provider pharmacist interviews highlighted the
importance of good counter staff who could
manage waiting customers. No pharmacist
mentioned difficulty with the record-keeping
required for the project. Pharmacists reported an
increase in their professional self-esteem. 
EMERGENCY HORMONAL CONTRACEPTION
Title, authors, source type, year and evidence
grading  Anderson C, Bissell P, Sharma S &
Sharma. R. Manchester, Salford and Trafford
Health Action Zone. 
Report into the provision of Emergency
Contraception in Community Pharmacy Via Patient
Group Directions. University of Nottingham (2001).
C1
Objectives  Aims were to assess the knowledge,
experiences and attitudes of service users (SUs); to
explore the perspectives of pharmacist providers;
to assess how pharmacists were operating the
service.
Study design  Questionnaire distributed to
service users by pharmacists. The 28-item
questionnaire was structured with space for
additional comments. A sample of SUs were asked
to participate in focus groups. 
Interviews with 24 pharmacists.
‘Mystery shopper’ evaluation with researchers
posing as SUs.
International literature review on emergency
hormonal contraception provision. 
Sampling and response rate  Of 5020
questionnaires distributed to 53 pharmacies, 490
were returned (9.8%).
Key findings  The age range of the 490
respondents was 15–52 years; a mean of 25. 37%
were in college or higher education, a quarter
were graduates and 14% were postgraduates.
17% were aged 19 years or under. Almost all the
Title, authors, source type, year and evidence
grading  Pharmacy Alliance.
Emergency hormonal contraception: Customer
survey. Report for Schering Healthcare (May
2002a).  C1
Objectives  To assess customers’ attitudes towards
availability, sale and supply of emergency
hormonal contraception (EHC) from the
community pharmacy, and any information needs
they may have; to establish women’s views on the
community pharmacy and the community
pharmacist as sources of EHC supply and advice.
Study design  Participating pharmacies (250)
were selected as study sites from respondents to a
pharmacist questionnaire. The questionnaire was
sent to 2219, and 1426 (64%) pharmacists
SUs (99%) said they were ‘very satisfied’ or
‘satisfied’ with the way their emergency hormonal
contraception (EHC) request had been handled.
99% indicated that they had received enough
information from the pharmacist. 85% felt there
was sufficient privacy; 80% were either
‘unconcerned’ or ‘very unconcerned’ about the
confidentiality of their enquiry for EHC; 19% were
‘concerned’ or ‘very concerned’ about
confidentiality and this was higher among under-
19 years (28%). 70% of those who had used EHC
before indicated that the pharmacy service was
‘much better’ than their previous service provider.
Awareness of the pharmacy service came from
friends and family (30%), TV or radio (26%), GP
(15%), pharmacy poster (14%) and NHS Direct
(9%). Respondents indicated that weekday
evenings, Saturday mornings, afternoons and
Sunday mornings were the most convenient time
to access EHC. Focus group data showed that some
participants had found it difficult to find out
which pharmacies were providing the service and
when they were open. A need was identified for
information and advertising about the service.
Most participating pharmacists expressed positive
views about the service for both SUs and
pharmacists. Some concerns were expressed about
the additional workload that providing the service
imposed, variability in remuneration practices
between different pharmacy chain employers and
lack of private space for conducting consultations.
Few pharmacists reported that repeated use of
EHC was a problem in practice. 
responded, of whom 435 were willing to take part
and 250 were selected to do so. Selection criteria
were speed of return of questionnaire and
numbers of packs of Levonelle sold (based on
Unichem data). Each pharmacist was asked to
recruit 10 EHC customers to complete the
consumer survey. A ‘customer refusal count sheet’
was provided to document refusals.
Sampling and response rate  The overall
response rate was 30% (785). There were three
groups of pharmacies: Pharmacy Alliance (PA),
Moss Pharmacies and Unichem Community
Pharmacy Initiative (CPI) scheme. Consumer
questionnaires were returned for 59%, 40% and
24% of these pharmacies respectively.  The
percentages of possible forms returned were 36%
PA, 24% Moss and 16% CPI.
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Key findings  The mean age of the 785
respondents was 26 years (range 14–53 years).
80.8% were white and 19.2% non-white. EHC was
received on prescription by 42.4%, over the
counter sale by 44% and Patient Group Direction
(PGD) by 13.6%. The 16–20 age group recorded
the highest level of access by PGD at 17.3%. Under
16-year olds received EHC on prescription in two-
thirds of cases and PGD in 14.3%, with 21.4% not
reporting a source. Women over 20 years were the
largest group and more likely to buy EHC over the
counter. Monday was the commonest day for
obtaining EHC (200, 27.7%), with Saturday 14.9%,
and no major differences between Saturday and
other days of the week. 71% of women accessed
Title, authors, source type, year and evidence
grading  Pharmacy Alliance.
Emergency hormonal contraception: Pharmacy
survey. Report for Schering Healthcare by
Pharmacy Alliance/Unichem (May 2002b).  B3
Objectives  To assess the attitudes of community
pharmacists in the UK towards the sale and supply
of emergency hormonal contraception (EHC) one
year after its deregulation to a P medicine; to
determine the training undertaken by pharmacists
and assistants on EHC; to determine the reasons
why some pharmacists do not supply EHC.
Study design  A structured postal questionnaire
was sent to all 2219 members of Pharmacy Alliance
(802), Moss Pharmacies (773) and UniChem’s
Community Pharmacy Initiative (CPI) scheme (644)
in England, Scotland and Wales. 
Sampling and response rate  Response rate was
56% after the initial mailing and 64% after one
reminder. Response rates were 76% (613)
Pharmacy Alliance; 72% Moss (554) and 40% (259)
CPI. The age and gender profiles of respondents
were compared with Royal Pharmaceutical Society
of Great Britain data and found to be similar.
There were no publicly available data with which
to compare the white/non-white respondent
profile.
Key findings  55% of respondents were male and
69% were white. The mean age of respondents
was 41 years. Overall 94% reported that they
worked regularly in the pharmacy from which the
survey was completed. Breakdown of respondents
EHC within 24 hours of unprotected intercourse.
Speed of access and convenience were the most
common reasons reported for purchasing EHC over
the counter. Prior to the current supply of EHC,
66.4% of women were aware that EHC was
available without a prescription. Respondents
rated a series of statements from 1 (strongly
disagree) to 5 (strongly agree). There was a high
level of satisfaction with the amount of advice and
information received, the median response being 4
for both. Pharmacies were highly rated as a
suitable place to obtain and discuss EHC, median
response 4 for both. Anonymity was cited by 9.7%
of respondents as a key reason for pharmacy
purchase of EHC. 
by professional status was 58% managers, 31%
owners, 7% locums (10% missing or other).
Almost all (98.9%) respondents said they would
supply EHC on prescription and 89.4% said they
would sell EHC over the counter (OTC). EHC was
being supplied under Patient Group Direction
(PGD) by 20% of respondents and a further 51%
who were not participating in a PGD scheme said
they would like to do so. Of the 284 pharmacists
involved in PGD schemes 66% (136) reported that
under 16-year olds were excluded.
Respondents were asked to rate a series of
statements from 1 (strongly agree) to 5 (strongly
disagree)  Pharmacists disagreed that OTC
availability had resulted in increased
promiscuity/sexual activity (median response
4).They supported the supply of EHC on PGD to
under 16-year olds (median response 2) and, while
they were not in favour of OTC availability for this
group (median response 4), they did not agree
that all under 16-year olds requesting EHC from a
pharmacy should be referred elsewhere. This
suggests that pharmacists wish to use their
professional judgement about supply. Pharmacists
did not agree that they had found it difficult to
deal with teenagers’ requests for EHC (median
response 4). Pharmacists felt that EHC availability
OTC had provided an opportunity to develop new
counselling skills (median response 2). They agreed
that the price of the OTC product was a deterrent
to patients buying it (median response 2).
Most (91%, 1302) pharmacists reported that they
had undertaken training on EHC. Centre for
Pharmacy Postgraduate Education (CPPE) 
workshops had been attended by 30% and CPPE
distance learning used by 56%. Manufacturers’
support information was used by 52%. 
Three-quarters of respondents reported having a
‘set protocol’ for sales of EHC. Women for whom
Title, authors, source type, year and evidence
grading  Seston E, Holden K & Cantrill J.
Deregulation of hormonal emergency
contraception: Pharmacists’ concerns and support
needs. Report for Royal Pharmaceutical Society of
Great Britain (2000).  B3
Objectives  To explore community pharmacists’
views on the deregulation of emergency hormonal
contraception (EHC) from POM to P (prescription
only medicine to pharmacy medicine) and to
examine training and support needs related to the
switch.
Study design  Focus groups with 14 community
pharmacists.
Sampling and response rate  Two groups were
held; one with community pharmacists already
providing EHC under a Patient Group Direction (8),
the other with no experience of providing EHC (6).
Pharmacists worked for a variety of employers
including multiples, small chains and
independents.
Title, authors, source type, year and evidence
grading  Edwards L.
Levonelle – P status and women’s needs:
qualitative research. Report for Schering Health
Care (2000).  B3
Objectives  To explore women’s information
needs in relation to the POM to P (prescription
only medicine to pharmacy medicine) switch of
emergency hormonal contraception (EHC).
Study design  Ten focus groups with women who
had used / might use EHC.
Sampling and response rate  Sampling
stratified by social class and age/lifestage. Each
group comprised half who were users of
emergency contraception and half who were non-
OTC EHC was identified as inappropriate were
referred to GPs by over 90% of respondents and to
Family Planning Clinics by around 60%.
Pharmacists reported little feedback from their
customers about positive or negative outcomes
after use of EHC. 
Key findings  Pharmacists were ‘poor’ at
identifying their own individual training needs.
Most participants supported mandatory training
before ‘prescribing’ deregulated EHC. Pharmacists
expressed concerns about ‘clinical’ issues and these
were generally ill-defined. Some participants were
concerned about how they would deal with under-
age clients. There was an identified need for
training for pharmacists in how to conduct
consultations for EHC in a non-judgemental
manner. Pharmacists in both focus groups
expressed concerns about possible ‘abuse’ of EHC
although the authors comment that many of these
concerns were based either on inaccurate
information or subjective assumptions. The
pharmacists who were already supplying EHC said
that their prior concerns had rarely materialised in
practice. The authors reported a sense that EHC
was accorded a special status by participants when
compared with other POM to P switches.
users but not ‘rejecters’. Those who said they
would ‘definitely’ only obtain EHC from the doctor
were excluded.
Key findings  Participants were positive about
convenience / accessibility of EHC following the
switch. However, concerns were expressed about
possible abuse of EHC. Key questions were: is it OK
for me to do this?; what will my experience be if I
do this?; what will happen to me afterwards?; Am
I in time?; How effective is it? ‘Myths’ identified
were worries about how often EHC could be taken
and whether it might affect fertility in the longer
term. The open pharmacy environment was a
major concern, as was confidentiality / what
records would be kept.
72
73
Title, authors, source type, year and evidence
grading  Williams A, Bond CM, Winfield AJ,
Calder G, Taylor R & Ritchie LD. 
A public health role for the community pharmacist:
a pilot study to identify patients who may be
considered for influenza vaccination. Report to the
Scottish Office (1993).  B3
Objectives  To assess the potential for a public
health role for community pharmacists using
influenza as a ‘tracer’ condition.
To assess the community pharmacist’s facility to
identify patients who may be candidates for
influenza immunisation. 
Study design  A systematic method (using patient
medication records: PMR) and an opportunistic
method (with customers asking for advice about
specific symptoms or for influenza or requesting
certain over the counter medicines) were used. The
systematic method was used in one health centre
pharmacy with 30,000 patient records on the PMR
system and the opportunistic method in 25
pharmacies. In the systematic method a list of ‘at
risk’ factors was compiled based on age and
prescribed medication. Patients were selected
randomly from the computer-maintained list and
their medication records checked for ‘at risk’
factors. Records were selected in this way until 250
eligible patients had been identified. The
computer file for each of these patients was then
flagged such that the patient would be identified
the next time they presented with a prescription.
‘At risk’ patients were asked to complete a short
questionnaire. Pharmacists in the ‘opportunistic’
study were each given 10 questionnaires to be
given to customers. 
Title, authors, source type, year and evidence
grading  Philips Z, Whynes D, Parnham S, Slack R
& Earwicker S.
The role of community pharmacists in counselling
patients and prescribing medication for the
treatment of head lice. Report commissioned by
the National Pharmaceutical Association
Nottingham University (1999).  B3
Objectives  To assess the usage, acceptability,
Sampling and response rate  In the
opportunistic study 37% of questionnaires were
returned.
Key findings  The systematic method using PMR
was effective in identifying patients who would be
candidates for influenza immunisation. 186
patients completed a questionnaire, 99% of whom
fell within an ‘at risk’ category. A significant
proportion of patients (69%) had not previously
been immunised against influenza, and this
percentage was lower in patients with asthma
(25%). The authors comment that the research
demonstrated that PMRs have valuable
applications other than those associated with the
dispensing process.
The opportunistic method showed some potential
but was hampered by a poor response from
community pharmacists. However, for the 74
people presenting with influenza-like symptoms,
97% were identified as having one or more ‘at
risk’ factors. Feedback from the pharmacists
indicated that lack of remuneration was the main
reason for the low participation rate. Further work
would be needed to confirm its value.
Other comments  The authors recommended
that: a national study using the PMR method
should be conducted with a concurrent advertising
programme and leaflets; that community
pharmacy data collection could be used to monitor
infectious disease outbreaks such as diarrhoea and
infestation; that remuneration should be given to
the pharmacist to cover time and the cost of
training staff.
effectiveness and effects on costs of community
pharmacy, rather than general practice, being the
first port of call for suspected head lice infestation
Study design  Before (3 months) and after (3
months) design in one health authority area
involving 32 community pharmacies in three
Primary Care Groups and 120,000 registered
patients. The scheme was continued beyond the
initial three months for a further 15 months and
IMMUNISATION
HEAD LICE
was monitored over this period. From January
1998 community pharmacy was promoted as the
principal source of advice and treatment for head
lice. After training, pharmacists provided
education and counselling. Proof of infestation
was required before treatment was recommended.
Pharmacists supplied treatment from an agreed
formulary where needed and were paid a fee
regardless of whether treatment was supplied.
Community pharmacists recorded prescriptions and
over the counter consultations about head lice for
three months prior to the study. During service
provision pharmacists used a Pharmacy Prescription
(PP1) form for both exempt and non-exempt
patients. Prescribing Analysis and Costs (PACT) data
were used to assess changes in prescribing of head
lice treatments. Questionnaire surveys of patients
(convenience sample of users) and health
professionals were conducted.
Sampling and response rate  Questionnaires
completed by 336 patients and 201 health
professionals (60 GPs, 42 pharmacists, 69
headteachers and 30 school nurses). No response
rates stated.
Key findings  Most of the 5710 scheme users in
the three-month evaluation period were female
(3846; 67.4%) and children (4383; 76.8%) and
exempt from prescription charges (5394; 94%). A
distinct trend away from consultations with the GP
and towards community pharmacy consultations
Title, authors, source type, year and evidence
grading  National Pharmaceutical Association.
Sunderland Integrated head lice infection
management service – an interim report. Report
for the National Pharmaceutical Association (2001).
B3
Objectives  To enable easier access to appropriate
treatment for head lice; to promote self-care.
Study design  Two primary care groups provided
a community pharmacy-based head lice
management service. Participating pharmacists
(initially from 32, later expanded to 47 pharmacies)
were required to participate in training to
facilitate consistency of advice. Head teachers were
also invited to the training. From September 1999,
GPs and community nurses were encouraged to
refer clients to the pharmacy and not to prescribe
head lice treatment. Pharmacists used a
was apparent within the first month of the scheme
and continued throughout the evaluation period,
with increasing self-referrals. Patients were
typically registered with a GP in the surrounding
area of the pharmacy used. No treatment was
recommended in one-third of consultations. Prior
to the scheme 30% of prescribed treatments were
non-formulary compared with over 99% formulary
during the scheme  (malathion and 50ml or 55ml
‘dose’). The ratio of prescribing of head lice
treatments in the study area to the rest of the
health authority area was 60% at baseline and fell
to under 25% demonstrating decreased GP
prescribing in the study area. Cost analysis showed
that community pharmacy consultations cost less
than GP consultations for head lice. The
questionnaire results showed that patients and
health professionals viewed the new arrangement
as at least as acceptable as the old.
In total 336 questionnaires were completed by
patients, most of whom were women. While the
overall findings suggest that the scheme was well-
received, 17.6% said they were embarrassed to
speak to the pharmacist about head lice. Around
half reported previous head lice infection. Health
professionals were generally positive about the
scheme, with GPs and school nurses finding it most
beneficial. Head teachers had some concerns about
the need for parental education and for parents to
take responsibility for checking hair and ensuring
treatment compliance.
prescription form HL1 to record consultations. The
formulary was malathion only, with a ‘dose’ of 2 x
50ml. The nursing team carried out a telephone
survey of a random sample of clients who had
used the service.
Sampling and response rate  Questionnaires
were sent to GPs (38% response), surgery staff
(54%), school nurses (68%), health visitors (28%),
head teachers (57%) and pharmacists (87%).
Key findings  Over a seven-month period 1847
clients accessed the service, with 1432 proving
infection for 2897 household members. Most
clients were female and children. The use of a
chemical insecticide was avoided in 415 suspected
infections. Pharmacists maintained 100%
compliance with the local formulary, so all clients
were treated in accordance with local guidelines.
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Prior to the service commencing, concerns had
been raised about a perceived lack of privacy in
community pharmacies. The client survey showed
that 42% said they were able to discuss their
problem in private, 34% said they were not able to
discuss their problem in private and 24% said they
were ‘not bothered’. The community pharmacy
service was rated as: excellent (28%), very good
(34%), good (20%), average (8%) and poor (4%).
Just over half the clients recalled having head lice
infection within the last two years. 98% reported
they had understood what the pharmacist had said
and 66% said their treatment was successful (10%
said it was not). 74% said they intended to use the
head lice detection comb (supplied by the
pharmacist) on a regular basis.
71% of GPs said that the service had reduced the
time they spent dealing with head lice infestation.
Overall 34% said they rarely (31%) or never (3%)
saw the client when prescribing head lice
treatment. Over 90% of health professionals said
they were happy for the service to continue and
the majority (67-85%) agreed that the service had
Title, authors, source type, year and evidence
grading  Thomas G.
A study of the advice and treatment recommended
for head lice infection in the Wrexham Local
Health Group area. MSc Thesis, Department of
Medicines Management, Keele University (2000).
B3
Objectives  To establish the thoughts and beliefs
of different professional groups on head lice
infestations and treatment.
Study design  Postal questionnaire to head
teachers of junior and primary schools, school
nurses, community pharmacists and GPs in one
Local Health Group area in Wales.
Sampling and response rate  Response rates:
65% (13 of 20) GPs; 90% (27 of 30) community
Title, authors, source type, year and evidence
grading  McGovern EM, Bryson SM, Lennie M,
Roddick E & Anderson C.
Use of head lice products in three Local Health
Care Co-operatives. Royal Pharmaceutical Society
of Great Britain Local Health Care Co-operative
‘made my life easier’. When asked if the service
should be extended to cover other conditions, 60%
of pharmacists, 66% of GPs, 52% of surgery staff,
62% of school nurses and 36% of health visitors
agreed.
Pharmacists were positive about the scheme and
93% said they would be happy to continue.
Pharmacists reported that 67% of initial
consultations took 5–10 minutes with 29% taking
less than 5 minutes and 5% more than 10 minutes.
Overall the cost of the new service was similar to
the previous equivalent period, even though twice
the quantity of treatment was supplied under the
new service in line with treatment guidelines
recommending two applications one week apart. 
Other comments  The authors comment that GP-
time was previously used in dealing with head lice.
They point out that the condition has no
associated health risks, implying that GP-time
freed by the scheme could be used to deal with
more serious conditions.
pharmacists; 84% (43 of 51) head teachers and
73% (11 of 15) school nurses.
Key findings  Head teachers and health
professionals were in agreement that head lice
infection was an increasing problem. Schools did
provide information to parents and that
information was sometimes out of date or in
conflict with that given by health professionals.
Head teachers and GPs tended to have a
preference for physical methods of head lice
removal and the results suggest that this might be
related to their thoughts on the safety and efficacy
of insecticides. Variation in the recommendations
made by different respondent groups had the
potential to confuse parents. The author
concluded that there was a need to develop a
consistent approach to advice and information on
detection and treatment of head lice.
Conference (2001).  C1
Objectives  To evaluate the use of head lice
preparations.
Study design  Thirty-four community pharmacies
recorded requests for head lice treatments for one
month. Data collected included insecticide
supplied, whether on prescription or over the
counter and whether live lice had been found by
the customer. The pharmacies also recorded when
advice was given and if not, why not.
Pharmacists also asked the customers to complete
a questionnaire.
Sampling and response rate  Of 62 pharmacies,
34 (55%) participated.
Questionnaires were returned by 184 (47%)
customers.
Key findings  Of 392 requests for head lice
products received, 219 (56%) were for over the
counter (OTC) supply. Most requests (344, 87%)
were for a pyrethroid product. Advice was
reported to have been given on 88% of occasions
unless the product had been used before (13) or
Title, authors, source type, year and evidence
grading  McGovern EM, Lindsay H, Taylor A &
Bryson SM.
Improving attitudes towards sugar-free medicines.
UK Clinical Pharmacy Association Conference
Proceedings, Blackpool (1999).  C1
Objectives  To determine pharmacists’ attitudes
and practice towards recommending sugar-free
medicines. 
Study design  Interviews were conducted with
100 community pharmacists in 1996 and repeated
in 1998. In the intervening period a sugar-free (SF)
substitution list was circulated to pharmacists, and
health promotion initiatives with support were
undertaken. Questions covered attitudes towards
provision of SF medicines, whether the pharmacist
might attempt to persuade a customer to change
to an SF version and advice offered when a sugar-
containing medicine was sold. Ten pharmacies
collected data for two weeks on all paediatric over
the counter medicines sold and customers were
asked about their attitudes towards SF medicines.
Key findings  In 1996 and 1998 respectively, 35%
and 64% of pharmacists said that sugar content of
advice had been given by the GP (10). Head lice
had been found by the customer on 297 (75%)
occasions.
127 (69%) of customers said they intended to
repeat the application and 69 (38%) intended to
treat the whole family or all children irrespective
of whether or not head lice was found. The
quantities of product supplied were less than those
recommended in current guidelines.
The authors note their concern that one-third of
customers did not intend to repeat the treatment
application and that over one-third intended to
treat irrespective of whether or not other family
members had head lice. It was concluded that the
high cost of OTC treatment may be a barrier to use
of appropriate quantities and to repeat
applications.
a medicine would affect their product
recommendation for a child. The percentage of
pharmacists saying they would try to persuade a
customer to change to a SF product increased from
45 to 69%. Offering dental advice when a sugar-
containing product was sold was reported by 8%
of pharmacists in 1996 and 21% in 1998. In the
intervening period 22 pharmacists had participated
in postgraduate education in oral health, 30 had
participated in a local health promotion initiative
on oral health and 76 reported having read
relevant articles.
Most medicines for children (over 85% in both
audits) were requested by name. Of the medicines
recommended by the pharmacist the percentage
that were SF increased from 55% to 100%. Most
customers (60–70%) believed SF medicines to be
important.
The authors note that pharmacists’ attitudes
towards SF medicines became more positive and
this resulted in increased provision. Nevertheless
they identified opportunities for further
improvement. They conclude that a more proactive
approach is needed, especially with those
customers who believe SF medicines are important.
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Title, authors, source type, year and evidence
grading  Reilly V, Bresnen G & McGovern EM.
An examination of the role of the community
pharmacist in managing stress and anxiety. MSc
Thesis, Liverpool John Moores University (2001).
C1
Objectives  To assess the involvement of
community pharmacists in the management of
stress and anxiety in one Local Health Care
Cooperative (LHCC).
Study design  Training evening held for
pharmacy staff in the LHCC area. Resource manual
produced for use by pharmacy staff. Interviews
conducted with 12 community pharmacists and 12
pharmacy assistants. Pharmacy customers were
asked to complete a questionnaire on frequency of
symptoms, any treatment purchased and preferred
sources of advice. Records were kept of leaflets on
mental health promotion issued by pharmacy staff
and self-selected by customers.
Sampling and response rate  Two-week study
Title, authors, source type, year and evidence
grading  Watson L, Bond CM & Gault C.
A survey of community pharmacists on prevention
of HIV and hepatitis B and C: current practice and
attitudes in Grampian. J Public Health (2003).  B3
Objectives  To assess the activity, knowledge and
attitudes of community pharmacists in Scotland in
prevention of HIV and hepatitis B and C infections.
Study design  Questionnaire survey of all 970
community pharmacies in 10 health boards in
Scotland.
Sampling and response rate  Response rate:
76% (740).
Key findings  Most pharmacies (70%) were
providing services for drug misusers. Nearly all
(97%) stocked condoms. 59% of pharmacists
period where pharmacy customers were asked to
complete the questionnaire.
Key findings  Feedback on the training was
positive, although not all LHCC staff attended.
Most (88%) of those interviewed thought it was
appropriate to offer advice about stress and
anxiety management in the pharmacy. At least two
symptoms of stress/anxiety were recognised by
two-thirds of interviewees. Just over half of those
interviewed knew about local self-help groups.
150 (90% response) customers completed the
questionnaire. 88% reported that they had
experienced symptoms of stress/anxiety and 49
(33%) had purchased a remedy.
Most people (76%) said the GP was their preferred
source of advice on stress/anxiety, friends (36%)
and pharmacist (13%).
866 leaflets were selected by customers with a
median of 98 per pharmacy (range 41–155). The
most popular resources were sleep and relaxation
guides.
reported stocking extra strong condoms and two
stocked dental dams. Just under two-thirds said
they stocked leaflets relating to safer sex, HIV or
hepatitis.
Fewer than half reported having contact lists for
local agencies dealing with drug-related or sexual
health problems. Knowledge of blood-borne
pathogens was mixed and pharmacists’ confidence
in advice-giving was greater for HIV than for
either hepatitis B or C. Few pharmacists were
aware of recommendations for hepatitis B
vaccination. Most felt that in the future
pharmacists could have a greater role in
prevention of these infections. The main barriers
to greater involvement were time pressure, lack of
a private area and lack of training.
PREVENTION OF TRANSMISSION OF INFECTION
MENTAL HEALTH
Title, authors, source type, year and evidence
grading  Martin-Hamblin-GfK. 
Osteoporosis Pharmacy Pilot Study (June 2002).  B3
Objectives  
(1) To evaluate whether an osteoporosis screening 
service model is effective from the perspective
of patients, GPs, the primary care team and the
pharmacist. 
(2) To understand if the community pharmacy is an 
effective/suitable forum to identify patients at
high risk of future fracture. 
(3) To gain an understanding of the programme’s 
impact on patients’ perception of the role of
the pharmacy and the perceived benefits to
patients.
(4) To understand if the Patient Group Direction 
element of the service model is effective to
allow timely access to treatment (not
implemented, as Patient Group Direction not
available for the pilot).
Study design  Pilot osteoporosis screening
scheme based in one community pharmacy.
Telephone interviews with clients (29 low risk from
assessment questionnaire; 75 low risk from bone
scan; 29 osteoporotic). Unstructured interviews
with health professionals (pharmacist, pharmacy
assistants, nurse, GPs, pharmaceutical advisors).
Face to face interviews with pharmacy users in the
target age group (60+ years).
Key findings  Most clients were either invited to
take part by pharmacy staff (43%) or saw a poster
at the pharmacy (35%). Only 2% became aware of
the service through posters at the GP surgery. 228
Title, authors, source type, year and evidence
grading  McGovern EM, Tennant S & Mackay C.
Audit of returned medicines to community
pharmacies. Royal Pharmaceutical Society of Great
Britain Local Health Care Cooperative Conference
(2001).  C1
Objectives  To assess the quantities and types of
medicines returned to community pharmacies.
Study design  For four weeks 10 community
pharmacies recorded all medicines returned
excluding those dispensed more than 12 months
earlier and over the counter medicines. Data
patients completed a Risk Assessment
questionnaire, of whom 49 (21%) were found to
be low risk. The remainder had a bone scan and 36
were found to be osteoporotic.
Most patients rated pharmacy staff as
extremely/very accessible (90%) and professional
(83%). Over 90% rated the knowledgeability and
clarity of explanation by the nurse conducting the
bone scan as extremely/very. The availability of the
screening service at a local pharmacy was highly
valued (89% giving the top rating). Over three-
quarters valued the ability of the pharmacist to
prescribe medication without having to visit the
doctor. Three-quarters thought the pharmacy
setting was more convenient than their doctor’s
surgery although only just over a half said this
would make them more likely to use the service.
Most said they would use the screening
programme again and would recommend it to
others. 80% of patients felt they were treated
with complete privacy and confidentiality, with
18% reporting ‘a degree’ of privacy and
confidentiality and 2% not being treated with any
privacy and confidentiality. When asked to state
any perceived disadvantages, 5% said lack of
space, 4% problems with the shop environment
and 2% no proper waiting room. 1% said that
doctors were more knowledgeable.
Commitment and enthusiasm of those involved
was found to be a significant factor and the
authors say it should be ‘an important
consideration in the selection of pharmacies
involved in any future scheme’.
recorded included the name of the medicine,
quantity returned, reason for return and
originating GP practice. The cost of each returned
item was calculated.
Key findings  Over the four week period, 256
items with a value of £2411 were returned by 100
patients. The median number of returned items
was 2 (range 1–17). The main reasons for return of
medicines were because therapy had been altered
(54% of patients) or the patient had died (16% of
patients). Eleven patients (11%) returned 13 items
because of an adverse reaction. The main
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therapeutic category was cardiovascular (76 items,
30%). The authors report there was evidence of
excessive quantities having been prescribed. Three
pharmacies and two general practitioner surgeries
Title, authors, source type, year and evidence
grading  Aston University/MEL Research.
Consumer expectations of community
pharmaceutical services. Report to the Department
of Health (1991).  B3
Objectives  To determine consumer views of
health information leaflets.
Study design  Self-completion postal
questionnaire.
Consumers were asked if they had noticed any
written material (leaflets or booklets) available
free of charge at their pharmacy; if so, whether
they had taken any away; if so, whether they had
found the material useful.
Sampling and response rate  224 respondents.
Key findings  Nearly two-thirds of ‘high users’ of
pharmacies had noticed leaflets and 37% had both
noticed leaflets and taken them away to read. For
the ‘general population’ 48% had noticed leaflets
and 23% had noticed them and taken them away.
13% of high users had seen and taken leaflets and
rated them as very useful compared with 5% of
the general population. Customers in younger
accounted for 61% and 68% of the returns
respectively. The results were discussed locally and
the authors report that some changes to
prescribing frequency were agreed.
(under 30 years and 30–44 years) age groups were
more likely to have seen leaflets (70%). However,
these groups were less likely to have taken away
and read leaflets. In the ‘retired’ group, 40% had
seen them and  20% reported taking leaflets. Men
and women were equally likely to have noticed
leaflets but women were more likely to have taken
them away and read them.
Over a quarter of respondents reported difficulty
in identifying the pharmacist and a similar
proportion believe ‘the pharmacist prefers to keep
out of sight’.  
‘Two-thirds of respondents would like to be able
to talk to the pharmacist in private, while only 5%
had found and used such facilities to date’.
Leaflets passively displayed were missed by nearly
half the consumers.
The authors concluded ‘There are still many people
who are unaware of the pharmacist’s role as an
adviser on general health matters’.
Other comments  The authors comment that
elderly people were less likely to notice leaflets
and to take them away.
Factors affecting the effectiveness of community pharmacy-based
activities to improve health
Title, authors, source type, year and evidence
grading  Coggans N, Johnson L, McKellar S, Grant
L & Parr RM 
Health promotion in community pharmacy:
perceptions and expectations of consumers and
health professionals. Department of
Pharmaceutical Sciences, University of Strathclyde
Report commissioned by the Scottish Office (June
2000).  C1
Objectives  The aims were to identify: 
(1) the aspects of health promotion to which 
pharmacy customers were most receptive; 
(2) what methods are appropriate for delivery of 
pharmacy health promotion. 
Study design  Semi-structured interviews with
601 pharmacy customers; 30 pharmacists; 30
pharmacy assistants. Interviews were taped and
transcribed. Setting: five health bo]ard areas in
Scotland. Delphi panel of 24 stakeholders in
community health promotion for consensus on
how and in what ways community pharmacy can
contribute to the health of pharmacy customers.
Sampling and response rate  Twenty customers
were interviewed in each of 30 participating
pharmacies. Customers were approached when
they had completed their transaction (or
sometimes while waiting for their prescription to
be dispensed). No refusal rate stated.
Title, authors, source type, year and evidence
grading  Shafford A & Sharpe K.
The pharmacist as a health educator. Research
Report 24, Health Education Authority (1989).  B3
Objectives  To study the perceived and actual
needs of community pharmacists in order to
develop their role as health educators.
Study design  Self-completion postal survey. 
Pro forma diary of health enquiries.
Sampling and response rate  Survey sent to all
community pharmacists in North East Thames
Regional Health Authority (897). Response rate:
58% after two reminders. Comparison of
pharmacy ownership type of responders with
regional data showed a similar profile. Pro forma
diary of health enquiries completed by self-
selected sub-sample. The profile of pharmacy
ownership type was similar to regional profile.
Key findings  Of the survey respondents, 61.7%
reported having a suitable area or room for
confidential discussions. One in four pharmacies
had a consultation room. 74% reported that their
undergraduate education gave them ‘no’ or ‘poor’
training in advice-giving on health education
topics and 48% said this about their pre-
registration training.
Authors comment that the sample included a
higher proportion of women, older people and
professional people than the general population.
Key findings  Of the customers interviewed, 37%
had visited a pharmacy at least once a week, 17%
at least once a fortnight, and 32% at least once a
month. Women reported visiting pharmacies more
often than men. 86% were willing to discuss their
prescribed medicine with the pharmacist if they
were having problems. 84% were willing to seek
pharmacy advice about minor health problems.
Less than one-third (32%) were willing to seek
advice on healthy eating in the pharmacy. 22%
said that either they did not see this as part of the
role of community pharmacy or that it had not
occurred to them that pharmacies could provide
such advice. Among smokers who could be
considered to be contemplating quitting, 66% felt
positive about obtaining advice on smoking
cessation in the pharmacy. One-fifth (20%) were
willing to seek advice about exercise from the
pharmacy.
When asked about willingness to get help on a
sensitive or personal problem in the pharmacy,
33% said yes and 52% said no. The pharmacy was
perceived to provide adequate privacy for
discussion of sensitive topics by 18% of customers,
with 68% saying no. 68% believed their discussions
in the pharmacy would be confidential, the
remainder giving negative or uncertain responses.
Women were significantly more likely than men to
say that they would discuss a sensitive subject and
that confidentiality would be maintained.
Leaflets were seen by customers as a principal
source of information with 70% saying they
obtained information this way. Pharmacists
perceived sun protection, prescribed medicines and
smoking cessation as being the health topics most
acceptable to the public for pharmacy
involvement. Diet, exercise and ‘sensitive topics’
were seen as much less acceptable. Pharmacists
were ‘willing and eager’ to discuss a range of
health issues with customers, although there was
some reluctance in relation to lifestyle issues as
well as awareness of privacy as an issue.
The Delphi group rated priority targets:
1. Increase the proportion of customers who 
perceive there to be enough privacy in the
pharmacy to discuss something sensitive or
personal.
2. Increase the proportion of pharmacy customers 
who believe that all discussions with pharmacists
are treated as confidential.
3. Increase public willingness to use community 
pharmacy for smoking cessation.
4. Increase the proportion of customers willing to 
discuss any problems with their prescribed
medicines with the pharmacist.
5. Maximise the availability and potential of health 
education leaflets.
Increasing public willingness to use pharmacies for
advice on healthy eating and exercise were ranked
sixth and eighth respectively.
Other comments  The authors comment that:
(1) the findings indicate a widespread perception
that community pharmacy does not provide
sufficient privacy for discussion of sensitive topics;
(2) there is a need to reassure the public about
confidentiality being part of pharmacy’s
professional ethos.
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45% reported displaying health education leaflets
and 56% believed leaflets to be of ‘great’ or ‘very
great’ importance. Advice-giving was reported as
of ‘great importance’ on prescribed medicines by
52% of respondents; over the counter medicines
by 45% and health education by 18%.
Pro forma diaries of health enquiries showed that
3% of recorded enquiries were on general health
queries. The busiest time of day for these enquiries
coincided with the busiest time for dispensing. The
Title, authors, source type, year and evidence
grading  Hariri, S.
Multimedia health promotion in community
pharmacy. PhD thesis Department of Pharmacy,
King’s College, London (1998).  C1
Objectives  To investigate the usability of
multimedia touch screen kiosks as tools for health
promotion within the community pharmacy
setting; to examine the effect of such a kiosk on
the public’s use of their community pharmacy as a
source of health information.
Study design  A touch screen multimedia kiosk
with the CardioPharm program was installed
initially in three community pharmacies (study 1)
and subsequently in three supermarket pharmacies
(study 2). Data were collected as users accessed the
software. Observation was conducted in the
pharmacies (study 1). Interviews were conducted
with the pharmacists (study 1). Users in the three
supermarket pharmacies were asked to complete a
questionnaire.
Sampling and response rate  Questionnaire
response rate not known.
Key findings  The total numbers of user
time taken to deal with general health queries was
longer than that for symptom, OTC or dispensed
medicine queries.
The authors concluded that ‘at present, the
general public do not see the pharmacist as a
general source of health information’ and that ‘it
is important to educate and encourage the general
public to use the community pharmacist as a
source of general health information’.
interactions were 847 in study 1 and 11,590 in
study 2. The completion rates were 31% and 37%
respectively. Most users in both studies were aged
below 40 and had a healthy Body Mass Index (BMI)
of 25 or less.
There was a significant increase in the health
promotion activity of the pharmacies including
more queries to the pharmacist and higher
numbers of leaflets taken. Observation indicated
that some older customers required
encouragement and a demonstration by pharmacy
staff before they used the kiosk.
154 users completed the questionnaire in study 2.
Most agreed that touch screen systems were a
good method of providing information to the
public. The majority agreed that the pharmacy was
an appropriate environment for information
kiosks. None of the users reported having asked
pharmacy staff for information or advice.
Other comments  Most customers who accessed
the software were in younger age groups. The
reasons for the low completion rate are not
known. Consideration needs to be given to how to
engage older customers in use of such systems.
Stakeholder views
Title, authors, source type, year and evidence
grading  BMRB International
Baseline mapping study to define access to and
usage of community pharmacy. Report
commissioned by Royal Pharmaceutical Society of
Great Britain (March 1996).  B3
Objectives  To determine who uses what type of
pharmacy, when, for what (prescription medicine
related, over the counter medicine related, healthy
lifestyles) and in what locations.
Study design  Face-to-face, in-home structured
interviews with 517 adults aged 16 years or over.
Inclusion criterion was that respondents had used
a pharmacy for at least one of the core
components in the past year, either for themselves
or for someone else. 
Title, authors, source type, year and evidence
grading  Hassell K, Rogers A, Noyce P & Nicolaas G
The public’s use of community pharmacies as a
primary health care resource. Report to the
Community Pharmacy Research Consortium
(November 1998).  B3
Objectives  To map and describe what is currently
known about how the public use pharmacies. To
provide retrospective and prospective data on
pharmacy usage in the context of how other
primary and secondary resources are used. To
explore what influences the choice of primary care
service provider.
Study design  Review of published literature.
Secondary analysis of general population
household survey and health diary data. Linked
qualitative study of interviews with users and non-
Title, authors, source type, year and evidence
grading  Anderson C.
Health promotion by community pharmacists. PhD
thesis, King’s College, London (1997).  B3
Objectives  To investigate the effect of a training
programme on the role of community pharmacists
in health promotion; to investigate consumers’
perceptions of the community pharmacist’s role
Study design  Interviews with pharmacists in the
Barnet High Street Health (HSH) scheme (who had
participated in the training programme) and a
‘control’ area. Covert study of pharmacists’ advice
on smoking cessation in 20 HSH pharmacies and 20
controls. Consumer survey using questionnaire
administered in six HSH pharmacies. Telephone
survey of health authority pharmaceutical advisers
in England.
users of community pharmacies.
Sampling and response rate  Survey of health
status and health care use by 834 residents in 346
households. Sample drawn from three areas
(urban, suburban, market town/semi-rural).
Screening was used and frequent health service
users were over-sampled.
Health diaries completed by 549 people in 215
households. Interviews with sub-sample of 41 diary
respondents.
Key findings  Frequency of pharmacy use was
high, mainly restricted to the prescription service.
Most people self-managed their conditions, with
5.5% using the community pharmacy for advice.
The pharmacist’s profile was perceived as ‘that of a
drug expert – advising on medicines not illness’. 
Sampling and response rate  Ten HSH scheme
pharmacists and ten ‘controls’ were interviewed.
592 consumers took part in six participating
pharmacies in the HSH scheme.
Key findings  Interview data showed that the
HSH pharmacists were more actively involved in
health promotion and had a more holistic view of
health. They perceived different barriers to
implementing the health promotion role.
Pharmacists who received training had increased
knowledge of health promotion, they expressed a
desire to spend less time dispensing prescriptions
and more time advising customers.
The covert research showed that HSH pharmacists
spent significantly longer in the consultation on
smoking cessation and used leaflets more
appropriately.
Sampling and response rate  Random Location
Sampling was used, using Enumeration Districts as
sampling points, with quota sampling.
Key findings  Of those sampled, 94% were found
to have used a pharmacy in the last year for one of
the three core reasons. On average pharmacies
were used once a month, with women and
respondents with children under five years more
frequent users. Other frequent users were those in
inner cities and ‘striving’ ACORN (A Classification
of Residential Neighbourhoods) type. Least
frequent users were 16- to 24-year-olds and
‘expanding’ ACORN type. Usage levels were: 90%
prescriptions; 30% seeking advice on specific
symptoms/problems; 10% seeking general health
advice. 16- to 24-year-olds had a ‘particularly low’
usage for general health advice. Usage for this
reason was higher among women, respondents
with young children and C2DEs. Unsolicited health
related advice was reported by 14% of respondents.
Over half (53%) of the people receiving this advice
received it twice or more often.
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Consumers believed that the doctor was the best
and most convenient person to go to for advice
about staying healthy. 40% of consumers believed
that it was the ‘usual job’ of the pharmacist to
advise on staying healthy but only 15% had ever
asked for such advice. 
The telephone survey data showed that 57% of
health authorities reported at least some health
promotion activity.
Title, authors, source type, year and evidence
grading  Anonymous.
The Pharmacy Healthcare Scheme (Qualitative
study). Health Education Authority. Research
Report (1993).  B3
Objectives  To examine the overall work of the
Pharmacy Healthcare Scheme from the
pharmacist’s perspective; to look at the role of the
pharmacist in health promotion.
Study design  Qualitative interview study
conducted in parallel with quantitative survey.
Sampling and response rate  Letter of
invitation sent to 180 community pharmacies in
England (including London), Scotland and Wales.
Half were multiples and half independents. Half
were ‘in town’ and half ‘out of town’. 21% (39) of
pharmacists agreed to be interviewed, 24%
declined and 55% did not reply. London had an
11% agreement rate and Edinburgh 50%. Of the
39 interviewees 17 were from independents and
22 from multiples. 
Key findings  The approximate time split
between dispensing / responding to symptoms and
admin/paperwork was 70/30%. None of the
pharmacists identified a specific time allocation for
Title, authors, source type, year and evidence
grading  Health Promotion Authority Wales.
Pharmacy Health Care Scheme survey (Wales).
Report.. Health Promotion Authority Wales &
Welsh School of Pharmacy (1991).  B3
Objectives  Determine levels of  health promoting
activities by community pharmacists in Wales; to
identify practical measures to increase
involvement. 
Study design  Self-completion postal
questionnaire.
Sampling and response rate  1081 pharmacists
in Wales (all practising  pharmacists registered
since 1940). Response rate: 67% (724) after two
health promotion. The report states that 5% of
overall time (within dispensing / responding to
symptoms) was spent on health promotion.
Although pharmacists perceived health promotion
as important the researchers noted that:
‘pharmacists’ health promotion role is reactive not
proactive’; ‘the pharmacist’s role is very much
orientated towards medical advice, health
promotion happens during this process’; ‘advice is
provided to the public on request as pharmacists
do not provide health promotion advice directly’
and ‘the pharmacist’s health promotion role is
developing – moving away from pure dispensing.
‘A sizeable number’ of pharmacists believed that
the public do not recognise the extent of their
training and skills and see them as shopkeepers,
not health educators. Pharmacists reported being
isolated from the primary health care team, with
no structured or formal communication channels
and little collaborative work. 
Other comments  The report recommended
national publicity to raise public awareness of the
pharmacist’s role in health promotion. Research on
the public’s perceptions of pharmacy was also
recommended.
reminders. The authors state that 522 pharmacy
premises were represented in the survey returns.
Comparison of years registered, gender and
employment status for responders, late responders
and non-responders showed similar profiles. In
statistical analysis P<0.001 assigned as significant.
Key findings  Only 13.5% rated health promotion
as being of ‘little’ or ‘no’ importance. Figures for
specific services/ activities were: pregnancy testing
310; weight measurement 156;  sale of
needles/syringes 151; blood pressure measurement
80; needle / syringe exchange 40; cholesterol
testing 16; lung function testing 7. 106 and 118
respondents reported planning to introduce blood
pressure and cholesterol measurement respectively.
Title, authors, source type, year and evidence
grading  BMRB
Pharmacy Healthcare scheme (Quantitative study).
Health Education Authority. Report (1993).  B3
Objectives  Examine how pharmacists view their
role in health promotion and health education; to
obtain pharmacists’ views as users of the Pharmacy
Healthcare Scheme on its effectiveness.
Study design  Pre-piloted postal questionnaire.
Sampling and response rate  A total of 1986
community pharmacies were sampled from
London, rest of England, Scotland, Wales and
Northern Ireland. Response rate: 67% after one
reminder. A higher percentage (91%) of Boots
pharmacists replied cf. 64% of others. At analysis,
data were weighted to the profile of the original
sample to correct for differing response rates.
Key findings  Of respondents, 45% worked for
independents and 18% at multiples with 50
Title, authors, source type, year and evidence
grading  Dewsbury-Mason C
Community pharmacists and health promotion
training, activities and attitudes. MSc thesis,
University of Kent (1998).  B3
Study design  Cross-sectional survey.
Questionnaire to 100 community pharmacists in
one UK area.
Sampling and response rate  Response rate: 66%.
Title, authors, source type, year and evidence
grading  Elliott J.
The role of community pharmacists in  relation to
the primary health care team. Report
commissioned by the Health Education Authority
(1996).  B3
Objectives  Identify a sample of community
pharmacists working with the primary health care
branches. Most pharmacists reported that
Pharmacy Healthcare Scheme leaflets were left to
be picked up by customers with only a small
number of leaflets taken on the pharmacist’s
recommendation. The researchers note that ‘there
is clearly a desire amongst many pharmacists to
become more involved in the area of health
promotion and education’. 77% reported spending
one, two or three hours a week on health
promotion and most said this was increasing. 84%
reported insufficient financial incentives and 66%
insufficient time for health promotion. Pharmacists
were also ‘keen for the public to be better
educated about the role of pharmacists in health
care in general’. 
Other comments  Pharmacists ranked the relative
importance of pharmacists being able to give
informed advice on specific topics as: smoking
54%; diet/nutrition 37%; family planning 21%;
exercise 14%; drinking 13%. 
Key findings  A holistic view of health was not
predominant among community pharmacists and
only 5% identified health as ‘an absence of illness’.
86% of pharmacists said they would be willing to
undertake further training in health promotion.
Just over half (53%) had undertaken some training
in health promotion. Time, remuneration and
premises were seen as the main barriers to
involvement in health promotion.
team; areas of collaboration; the extent to which
the focus of collaboration involved health
promotion; identify barriers to team working. 
Study design  Postal survey of pharmacists
Interviews with health authority pharmaceutical
advisers (3), local pharmaceutical committee
secretaries (3), community pharmacists (15),
primary care team members (9).
Barriers to health promotion activities were
reported as: finance 54%; public apathy (34%);
professional relationships with GPs (31%) and lack
of knowledge (22%) . 
Other comments  Commentary notes that
‘Pharmaceutical Care: the future for community
pharmacy’ recommended that diagnostic and
screening services should be provided by
community pharmacies and discusses this aspect. 
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Sampling and response rate  Questionnaire
sent to 373 community pharmacists in three areas
(Cumbria, Liverpool, Northamptonshire). Response
rate: 78% (290) after one reminder.
Semi-structured interviews with sample of 15
community pharmacists (self-reported
collaboration with primary care team in
questionnaire) and other health professionals (9 of
16 agreed to be interviewed) identified by the sub-
sample of community pharmacists as working with
them.
Key findings  Regular meetings with primary
health care team reported by 14% of survey
respondents. Collaboration on projects or
initiatives reported by 13%. Collaboration focused
on prescribing and medicines. Pharmacists
dispensing higher prescription numbers were more
likely to report collaboration. Barriers to
collaboration were: lack of time; lack of funding;
lack of opportunity to meet other health
professionals; perception that pharmacist’s input
not wanted. Seven of 18 pharmacists who made
additional comments said they ‘had not been
asked’ to collaborate. Close proximity to the GP
practice with no other pharmacies nearby was
associated with collaboration.
Interview data suggested that survey results
overestimated the amount of collaboration and
teamwork (10 of 15 pharmacists self-reporting
collaborative work were doing so, the remainder
were minimal or intermittent).
Interviews with pharmaceutical advisers identified
local initiatives organised by health authorities.
However, these were ‘for limited time periods,
with limited funding and inadequate evaluation’
and generally involved an enthusiastic minority of
pharmacists. 
Other comments  One-third (32%) of pharmacists
reported that most of their prescriptions came
from one GP practice; 19% from two; 21% from
three to four; and 29% from more than four.
Title, authors, source type, year and evidence
grading  Scott K.
Involvement of community pharmacists in Health
Education Authority (HEA) primary health care
team workshops – Report on qualitative
evaluation. Report for HEA (1994).  B3
Objectives  To explore: community pharmacists’
perceptions of their role within primary care;
primary health care team PHCT workers’
perceptions of the community pharmacist; the
nature and extent of working relationships; initial
and longer term impact of pharmacist involvement
in PHCT workshops.
Study design  Nine practice teams were involved.
Pre-workshop interviews with eight pharmacists
and 36 PHCT members. Interviews one week post-
workshop with eight pharmacists and 32 PHCT
members. Unclear how PHCT members were
selected. Three months post-workshop, group
interview with eight pharmacists and postal
questionnaire to PHCT members (21 respondents).
Sampling and response rate  Response rates:
100% stage 1; 90% stage 2; 72% stage 3.
Key findings  Community pharmacists were rarely
mentioned spontaneously as part of the PHCT.
Although PHCT members expressed confidence in
individual pharmacists they often expressed
concerns about community pharmacy in general in
relation to possible wider roles. The main concerns
were about pharmacists’ lack of access to patients’
full medical history and about potential conflicts
arising from commercial activities. Nevertheless
most PHCT members (particularly GPs, practice
managers, practice nurses and district nurses)
welcomed the idea of greater involvement of
community pharmacists.
While the community pharmacists were pleased to
be invited to attend the workshop they also
expressed anxieties about what they would be
able to contribute and about how their
participation would be received by PHCT members.
Three months after the workshop there was
evidence of greater contact (pharmacists invited to
practice meetings by most practices) and a number
of joint activities (e.g. referral of diabetic patients
to the pharmacy by the diabetic nurse and vice
versa; joint GP/pharmacist asthma session for
school nurses). Both pharmacists and practices
reported difficulties in pharmacists being able to
leave their premises to attend practice meetings.
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What role, if any, should pharmacies play in
improving the health and well-being of the
general public? Situated, as they often are,
at the heart of their communities, they are
in a unique position to provide help and
advice on health matters to a complete
cross-section of society at the same time as
dispensing medicines. But is there any
evidence that customers would actually
benefit from such advice?
Bringing together, summarising and
categorising research papers on such diverse
topics as stopping smoking, lipid
management and drug misuse, this report
provides strong evidence that pharmacies
can indeed make a positive contribution to
improving the health of the nation – a
finding that supports the recommendation
of the recent Health Committee Inquiry into
Public Health that ‘community pharmacists
play a more active role in public health’. 
By adopting some of the activities described,
pharmacies across the country will not only
be aiding the treatment of disease they will
be improving the health of their customers
at the same time. This report will make
interesting reading for all those concerned
with meeting health improvement targets,
planning future services and integrating
community pharmacy activity with that of
the wider NHS.
